<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-07-11" modified="2024-10-02" version="232" xmlns="http://uniprot.org/uniprot">
  <accession>Q13283</accession>
  <accession>Q5HYE9</accession>
  <name>G3BP1_HUMAN</name>
  <protein>
    <recommendedName>
      <fullName>Ras GTPase-activating protein-binding protein 1</fullName>
      <shortName>G3BP-1</shortName>
      <ecNumber evidence="39">3.6.4.12</ecNumber>
      <ecNumber evidence="39">3.6.4.13</ecNumber>
    </recommendedName>
    <alternativeName>
      <fullName>ATP-dependent DNA helicase VIII</fullName>
      <shortName>hDH VIII</shortName>
    </alternativeName>
    <alternativeName>
      <fullName>GAP SH3 domain-binding protein 1</fullName>
    </alternativeName>
  </protein>
  <gene>
    <name evidence="43 45" type="primary">G3BP1</name>
    <name type="synonym">G3BP</name>
  </gene>
  <organism>
    <name type="scientific">Homo sapiens</name>
    <name type="common">Human</name>
    <dbReference type="NCBI Taxonomy" id="9606"/>
    <lineage>
      <taxon>Eukaryota</taxon>
      <taxon>Metazoa</taxon>
      <taxon>Chordata</taxon>
      <taxon>Craniata</taxon>
      <taxon>Vertebrata</taxon>
      <taxon>Euteleostomi</taxon>
      <taxon>Mammalia</taxon>
      <taxon>Eutheria</taxon>
      <taxon>Euarchontoglires</taxon>
      <taxon>Primates</taxon>
      <taxon>Haplorrhini</taxon>
      <taxon>Catarrhini</taxon>
      <taxon>Hominidae</taxon>
      <taxon>Homo</taxon>
    </lineage>
  </organism>
  <reference key="1">
    <citation type="journal article" date="1996" name="Mol. Cell. Biol." volume="16" first="2561" last="2569">
      <title>A Ras-GTPase-activating protein SH3-domain-binding protein.</title>
      <authorList>
        <person name="Parker F."/>
        <person name="Maurier F."/>
        <person name="Delumeau I."/>
        <person name="Duchesne M."/>
        <person name="Faucher D."/>
        <person name="Debussche L."/>
        <person name="Dugue A."/>
        <person name="Schweighoffer F."/>
        <person name="Tocque B."/>
      </authorList>
      <dbReference type="PubMed" id="8649363"/>
      <dbReference type="DOI" id="10.1128/mcb.16.6.2561"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
    <scope>TISSUE SPECIFICITY</scope>
    <source>
      <tissue>Placenta</tissue>
    </source>
  </reference>
  <reference key="2">
    <citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
      <title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
      <authorList>
        <person name="Ota T."/>
        <person name="Suzuki Y."/>
        <person name="Nishikawa T."/>
        <person name="Otsuki T."/>
        <person name="Sugiyama T."/>
        <person name="Irie R."/>
        <person name="Wakamatsu A."/>
        <person name="Hayashi K."/>
        <person name="Sato H."/>
        <person name="Nagai K."/>
        <person name="Kimura K."/>
        <person name="Makita H."/>
        <person name="Sekine M."/>
        <person name="Obayashi M."/>
        <person name="Nishi T."/>
        <person name="Shibahara T."/>
        <person name="Tanaka T."/>
        <person name="Ishii S."/>
        <person name="Yamamoto J."/>
        <person name="Saito K."/>
        <person name="Kawai Y."/>
        <person name="Isono Y."/>
        <person name="Nakamura Y."/>
        <person name="Nagahari K."/>
        <person name="Murakami K."/>
        <person name="Yasuda T."/>
        <person name="Iwayanagi T."/>
        <person name="Wagatsuma M."/>
        <person name="Shiratori A."/>
        <person name="Sudo H."/>
        <person name="Hosoiri T."/>
        <person name="Kaku Y."/>
        <person name="Kodaira H."/>
        <person name="Kondo H."/>
        <person name="Sugawara M."/>
        <person name="Takahashi M."/>
        <person name="Kanda K."/>
        <person name="Yokoi T."/>
        <person name="Furuya T."/>
        <person name="Kikkawa E."/>
        <person name="Omura Y."/>
        <person name="Abe K."/>
        <person name="Kamihara K."/>
        <person name="Katsuta N."/>
        <person name="Sato K."/>
        <person name="Tanikawa M."/>
        <person name="Yamazaki M."/>
        <person name="Ninomiya K."/>
        <person name="Ishibashi T."/>
        <person name="Yamashita H."/>
        <person name="Murakawa K."/>
        <person name="Fujimori K."/>
        <person name="Tanai H."/>
        <person name="Kimata M."/>
        <person name="Watanabe M."/>
        <person name="Hiraoka S."/>
        <person name="Chiba Y."/>
        <person name="Ishida S."/>
        <person name="Ono Y."/>
        <person name="Takiguchi S."/>
        <person name="Watanabe S."/>
        <person name="Yosida M."/>
        <person name="Hotuta T."/>
        <person name="Kusano J."/>
        <person name="Kanehori K."/>
        <person name="Takahashi-Fujii A."/>
        <person name="Hara H."/>
        <person name="Tanase T.-O."/>
        <person name="Nomura Y."/>
        <person name="Togiya S."/>
        <person name="Komai F."/>
        <person name="Hara R."/>
        <person name="Takeuchi K."/>
        <person name="Arita M."/>
        <person name="Imose N."/>
        <person name="Musashino K."/>
        <person name="Yuuki H."/>
        <person name="Oshima A."/>
        <person name="Sasaki N."/>
        <person name="Aotsuka S."/>
        <person name="Yoshikawa Y."/>
        <person name="Matsunawa H."/>
        <person name="Ichihara T."/>
        <person name="Shiohata N."/>
        <person name="Sano S."/>
        <person name="Moriya S."/>
        <person name="Momiyama H."/>
        <person name="Satoh N."/>
        <person name="Takami S."/>
        <person name="Terashima Y."/>
        <person name="Suzuki O."/>
        <person name="Nakagawa S."/>
        <person name="Senoh A."/>
        <person name="Mizoguchi H."/>
        <person name="Goto Y."/>
        <person name="Shimizu F."/>
        <person name="Wakebe H."/>
        <person name="Hishigaki H."/>
        <person name="Watanabe T."/>
        <person name="Sugiyama A."/>
        <person name="Takemoto M."/>
        <person name="Kawakami B."/>
        <person name="Yamazaki M."/>
        <person name="Watanabe K."/>
        <person name="Kumagai A."/>
        <person name="Itakura S."/>
        <person name="Fukuzumi Y."/>
        <person name="Fujimori Y."/>
        <person name="Komiyama M."/>
        <person name="Tashiro H."/>
        <person name="Tanigami A."/>
        <person name="Fujiwara T."/>
        <person name="Ono T."/>
        <person name="Yamada K."/>
        <person name="Fujii Y."/>
        <person name="Ozaki K."/>
        <person name="Hirao M."/>
        <person name="Ohmori Y."/>
        <person name="Kawabata A."/>
        <person name="Hikiji T."/>
        <person name="Kobatake N."/>
        <person name="Inagaki H."/>
        <person name="Ikema Y."/>
        <person name="Okamoto S."/>
        <person name="Okitani R."/>
        <person name="Kawakami T."/>
        <person name="Noguchi S."/>
        <person name="Itoh T."/>
        <person name="Shigeta K."/>
        <person name="Senba T."/>
        <person name="Matsumura K."/>
        <person name="Nakajima Y."/>
        <person name="Mizuno T."/>
        <person name="Morinaga M."/>
        <person name="Sasaki M."/>
        <person name="Togashi T."/>
        <person name="Oyama M."/>
        <person name="Hata H."/>
        <person name="Watanabe M."/>
        <person name="Komatsu T."/>
        <person name="Mizushima-Sugano J."/>
        <person name="Satoh T."/>
        <person name="Shirai Y."/>
        <person name="Takahashi Y."/>
        <person name="Nakagawa K."/>
        <person name="Okumura K."/>
        <person name="Nagase T."/>
        <person name="Nomura N."/>
        <person name="Kikuchi H."/>
        <person name="Masuho Y."/>
        <person name="Yamashita R."/>
        <person name="Nakai K."/>
        <person name="Yada T."/>
        <person name="Nakamura Y."/>
        <person name="Ohara O."/>
        <person name="Isogai T."/>
        <person name="Sugano S."/>
      </authorList>
      <dbReference type="PubMed" id="14702039"/>
      <dbReference type="DOI" id="10.1038/ng1285"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
    <source>
      <tissue>Pericardium</tissue>
    </source>
  </reference>
  <reference key="3">
    <citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
      <title>The full-ORF clone resource of the German cDNA consortium.</title>
      <authorList>
        <person name="Bechtel S."/>
        <person name="Rosenfelder H."/>
        <person name="Duda A."/>
        <person name="Schmidt C.P."/>
        <person name="Ernst U."/>
        <person name="Wellenreuther R."/>
        <person name="Mehrle A."/>
        <person name="Schuster C."/>
        <person name="Bahr A."/>
        <person name="Bloecker H."/>
        <person name="Heubner D."/>
        <person name="Hoerlein A."/>
        <person name="Michel G."/>
        <person name="Wedler H."/>
        <person name="Koehrer K."/>
        <person name="Ottenwaelder B."/>
        <person name="Poustka A."/>
        <person name="Wiemann S."/>
        <person name="Schupp I."/>
      </authorList>
      <dbReference type="PubMed" id="17974005"/>
      <dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
    <source>
      <tissue>Adipose tissue</tissue>
    </source>
  </reference>
  <reference key="4">
    <citation type="journal article" date="2004" name="Nature" volume="431" first="268" last="274">
      <title>The DNA sequence and comparative analysis of human chromosome 5.</title>
      <authorList>
        <person name="Schmutz J."/>
        <person name="Martin J."/>
        <person name="Terry A."/>
        <person name="Couronne O."/>
        <person name="Grimwood J."/>
        <person name="Lowry S."/>
        <person name="Gordon L.A."/>
        <person name="Scott D."/>
        <person name="Xie G."/>
        <person name="Huang W."/>
        <person name="Hellsten U."/>
        <person name="Tran-Gyamfi M."/>
        <person name="She X."/>
        <person name="Prabhakar S."/>
        <person name="Aerts A."/>
        <person name="Altherr M."/>
        <person name="Bajorek E."/>
        <person name="Black S."/>
        <person name="Branscomb E."/>
        <person name="Caoile C."/>
        <person name="Challacombe J.F."/>
        <person name="Chan Y.M."/>
        <person name="Denys M."/>
        <person name="Detter J.C."/>
        <person name="Escobar J."/>
        <person name="Flowers D."/>
        <person name="Fotopulos D."/>
        <person name="Glavina T."/>
        <person name="Gomez M."/>
        <person name="Gonzales E."/>
        <person name="Goodstein D."/>
        <person name="Grigoriev I."/>
        <person name="Groza M."/>
        <person name="Hammon N."/>
        <person name="Hawkins T."/>
        <person name="Haydu L."/>
        <person name="Israni S."/>
        <person name="Jett J."/>
        <person name="Kadner K."/>
        <person name="Kimball H."/>
        <person name="Kobayashi A."/>
        <person name="Lopez F."/>
        <person name="Lou Y."/>
        <person name="Martinez D."/>
        <person name="Medina C."/>
        <person name="Morgan J."/>
        <person name="Nandkeshwar R."/>
        <person name="Noonan J.P."/>
        <person name="Pitluck S."/>
        <person name="Pollard M."/>
        <person name="Predki P."/>
        <person name="Priest J."/>
        <person name="Ramirez L."/>
        <person name="Retterer J."/>
        <person name="Rodriguez A."/>
        <person name="Rogers S."/>
        <person name="Salamov A."/>
        <person name="Salazar A."/>
        <person name="Thayer N."/>
        <person name="Tice H."/>
        <person name="Tsai M."/>
        <person name="Ustaszewska A."/>
        <person name="Vo N."/>
        <person name="Wheeler J."/>
        <person name="Wu K."/>
        <person name="Yang J."/>
        <person name="Dickson M."/>
        <person name="Cheng J.-F."/>
        <person name="Eichler E.E."/>
        <person name="Olsen A."/>
        <person name="Pennacchio L.A."/>
        <person name="Rokhsar D.S."/>
        <person name="Richardson P."/>
        <person name="Lucas S.M."/>
        <person name="Myers R.M."/>
        <person name="Rubin E.M."/>
      </authorList>
      <dbReference type="PubMed" id="15372022"/>
      <dbReference type="DOI" id="10.1038/nature02919"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="5">
    <citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
      <title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
      <authorList>
        <consortium name="The MGC Project Team"/>
      </authorList>
      <dbReference type="PubMed" id="15489334"/>
      <dbReference type="DOI" id="10.1101/gr.2596504"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
    <source>
      <tissue>Prostate</tissue>
    </source>
  </reference>
  <reference key="6">
    <citation type="submission" date="2008-12" db="UniProtKB">
      <authorList>
        <person name="Bienvenut W.V."/>
        <person name="Heiserich L."/>
        <person name="Boulahbel H."/>
        <person name="Gottlieb E."/>
        <person name="Calvo F."/>
        <person name="Zebisch A."/>
        <person name="Lilla S."/>
        <person name="von Kriegsheim A."/>
        <person name="Lempens A."/>
        <person name="Kolch W."/>
      </authorList>
    </citation>
    <scope>PROTEIN SEQUENCE OF 2-13; 18-32; 37-59; 65-76; 108-132; 230-276; 308-314; 321-331; 336-370; 377-403; 430-443 AND 448-465</scope>
    <scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
    <scope>METHYLATION AT ARG-435 AND ARG-460</scope>
    <scope>PHOSPHORYLATION AT SER-231 AND SER-232</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
      <tissue>Colon carcinoma</tissue>
      <tissue>Ovarian carcinoma</tissue>
    </source>
  </reference>
  <reference key="7">
    <citation type="journal article" date="1999" name="Nucleic Acids Res." volume="27" first="817" last="821">
      <title>Human DNA helicase VIII: a DNA and RNA helicase corresponding to the G3BP protein, an element of the ras transduction pathway.</title>
      <authorList>
        <person name="Costa M."/>
        <person name="Ochem A."/>
        <person name="Staub A."/>
        <person name="Falaschi A."/>
      </authorList>
      <dbReference type="PubMed" id="9889278"/>
      <dbReference type="DOI" id="10.1093/nar/27.3.817"/>
    </citation>
    <scope>PROTEIN SEQUENCE OF 248-257; 336-353; 394-403 AND 444-463</scope>
    <scope>FUNCTION AS A HELICASE</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>COFACTOR</scope>
  </reference>
  <reference key="8">
    <citation type="journal article" date="2001" name="Mol. Cell. Biol." volume="21" first="7747" last="7760">
      <title>RasGAP-associated endoribonuclease G3Bp: selective RNA degradation and phosphorylation-dependent localization.</title>
      <authorList>
        <person name="Tourriere H."/>
        <person name="Gallouzi I.-E."/>
        <person name="Chebli K."/>
        <person name="Capony J.-P."/>
        <person name="Mouaikel J."/>
        <person name="van der Geer P."/>
        <person name="Tazi J."/>
      </authorList>
      <dbReference type="PubMed" id="11604510"/>
      <dbReference type="DOI" id="10.1128/mcb.21.22.7747-7760.2001"/>
    </citation>
    <scope>FUNCTION AS AN ENDORIBONUCLEASE</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>PHOSPHORYLATION AT SER-149 AND SER-232</scope>
    <scope>MUTAGENESIS OF SER-149 AND SER-232</scope>
  </reference>
  <reference key="9">
    <citation type="journal article" date="2001" name="Oncogene" volume="20" first="3869" last="3879">
      <title>Ras-GAP SH3 domain binding protein (G3BP) is a modulator of USP10, a novel human ubiquitin specific protease.</title>
      <authorList>
        <person name="Soncini C."/>
        <person name="Berdo I."/>
        <person name="Draetta G."/>
      </authorList>
      <dbReference type="PubMed" id="11439350"/>
      <dbReference type="DOI" id="10.1038/sj.onc.1204553"/>
    </citation>
    <scope>INTERACTION WITH USP10</scope>
  </reference>
  <reference key="10">
    <citation type="journal article" date="2003" name="J. Cell Biol." volume="160" first="823" last="831">
      <title>The RasGAP-associated endoribonuclease G3BP assembles stress granules.</title>
      <authorList>
        <person name="Tourriere H."/>
        <person name="Chebli K."/>
        <person name="Zekri L."/>
        <person name="Courselaud B."/>
        <person name="Blanchard J.-M."/>
        <person name="Bertrand E."/>
        <person name="Tazi J."/>
      </authorList>
      <dbReference type="PubMed" id="12642610"/>
      <dbReference type="DOI" id="10.1083/jcb.200212128"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>RECRUITMENT TO STRESS GRANULES</scope>
    <scope>DIMERIZATION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>PHOSPHORYLATION</scope>
    <scope>MUTAGENESIS OF SER-149</scope>
  </reference>
  <reference key="11">
    <citation type="journal article" date="2004" name="Anal. Chem." volume="76" first="2763" last="2772">
      <title>Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.</title>
      <authorList>
        <person name="Brill L.M."/>
        <person name="Salomon A.R."/>
        <person name="Ficarro S.B."/>
        <person name="Mukherji M."/>
        <person name="Stettler-Gill M."/>
        <person name="Peters E.C."/>
      </authorList>
      <dbReference type="PubMed" id="15144186"/>
      <dbReference type="DOI" id="10.1021/ac035352d"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Leukemic T-cell</tissue>
    </source>
  </reference>
  <reference key="12">
    <citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
      <title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
      <authorList>
        <person name="Olsen J.V."/>
        <person name="Blagoev B."/>
        <person name="Gnad F."/>
        <person name="Macek B."/>
        <person name="Kumar C."/>
        <person name="Mortensen P."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="17081983"/>
      <dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-149</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="13">
    <citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
      <title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
      <authorList>
        <person name="Beausoleil S.A."/>
        <person name="Villen J."/>
        <person name="Gerber S.A."/>
        <person name="Rush J."/>
        <person name="Gygi S.P."/>
      </authorList>
      <dbReference type="PubMed" id="16964243"/>
      <dbReference type="DOI" id="10.1038/nbt1240"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="14">
    <citation type="journal article" date="2007" name="Electrophoresis" volume="28" first="2027" last="2034">
      <title>Toward a global characterization of the phosphoproteome in prostate cancer cells: identification of phosphoproteins in the LNCaP cell line.</title>
      <authorList>
        <person name="Giorgianni F."/>
        <person name="Zhao Y."/>
        <person name="Desiderio D.M."/>
        <person name="Beranova-Giorgianni S."/>
      </authorList>
      <dbReference type="PubMed" id="17487921"/>
      <dbReference type="DOI" id="10.1002/elps.200600782"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Prostate cancer</tissue>
    </source>
  </reference>
  <reference key="15">
    <citation type="journal article" date="2007" name="Mol. Cell. Biol." volume="27" first="2324" last="2342">
      <title>Distinct structural features of caprin-1 mediate its interaction with G3BP-1 and its induction of phosphorylation of eukaryotic translation initiation factor 2alpha, entry to cytoplasmic stress granules, and selective interaction with a subset of mRNAs.</title>
      <authorList>
        <person name="Solomon S."/>
        <person name="Xu Y."/>
        <person name="Wang B."/>
        <person name="David M.D."/>
        <person name="Schubert P."/>
        <person name="Kennedy D."/>
        <person name="Schrader J.W."/>
      </authorList>
      <dbReference type="PubMed" id="17210633"/>
      <dbReference type="DOI" id="10.1128/mcb.02300-06"/>
    </citation>
    <scope>INTERACTION WITH CAPRIN1</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="16">
    <citation type="journal article" date="2007" name="Mol. Cell. Proteomics" volume="6" first="1952" last="1967">
      <title>Quantitative phosphoproteome profiling of Wnt3a-mediated signaling network: indicating the involvement of ribonucleoside-diphosphate reductase M2 subunit phosphorylation at residue serine 20 in canonical Wnt signal transduction.</title>
      <authorList>
        <person name="Tang L.-Y."/>
        <person name="Deng N."/>
        <person name="Wang L.-S."/>
        <person name="Dai J."/>
        <person name="Wang Z.-L."/>
        <person name="Jiang X.-S."/>
        <person name="Li S.-J."/>
        <person name="Li L."/>
        <person name="Sheng Q.-H."/>
        <person name="Wu D.-Q."/>
        <person name="Li L."/>
        <person name="Zeng R."/>
      </authorList>
      <dbReference type="PubMed" id="17693683"/>
      <dbReference type="DOI" id="10.1074/mcp.m700120-mcp200"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-149</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Embryonic kidney</tissue>
    </source>
  </reference>
  <reference key="17">
    <citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
      <title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
      <authorList>
        <person name="Cantin G.T."/>
        <person name="Yi W."/>
        <person name="Lu B."/>
        <person name="Park S.K."/>
        <person name="Xu T."/>
        <person name="Lee J.-D."/>
        <person name="Yates J.R. III"/>
      </authorList>
      <dbReference type="PubMed" id="18220336"/>
      <dbReference type="DOI" id="10.1021/pr0705441"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-149</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="18">
    <citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="5167" last="5176">
      <title>Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment.</title>
      <authorList>
        <person name="Carrascal M."/>
        <person name="Ovelleiro D."/>
        <person name="Casas V."/>
        <person name="Gay M."/>
        <person name="Abian J."/>
      </authorList>
      <dbReference type="PubMed" id="19367720"/>
      <dbReference type="DOI" id="10.1021/pr800500r"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>T-cell</tissue>
    </source>
  </reference>
  <reference key="19">
    <citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
      <title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
      <authorList>
        <person name="Daub H."/>
        <person name="Olsen J.V."/>
        <person name="Bairlein M."/>
        <person name="Gnad F."/>
        <person name="Oppermann F.S."/>
        <person name="Korner R."/>
        <person name="Greff Z."/>
        <person name="Keri G."/>
        <person name="Stemmann O."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="18691976"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-149</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="20">
    <citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
      <title>A quantitative atlas of mitotic phosphorylation.</title>
      <authorList>
        <person name="Dephoure N."/>
        <person name="Zhou C."/>
        <person name="Villen J."/>
        <person name="Beausoleil S.A."/>
        <person name="Bakalarski C.E."/>
        <person name="Elledge S.J."/>
        <person name="Gygi S.P."/>
      </authorList>
      <dbReference type="PubMed" id="18669648"/>
      <dbReference type="DOI" id="10.1073/pnas.0805139105"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-143; SER-149; SER-232 AND SER-373</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="21">
    <citation type="journal article" date="2008" name="Proteomics" volume="8" first="1346" last="1361">
      <title>Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography.</title>
      <authorList>
        <person name="Han G."/>
        <person name="Ye M."/>
        <person name="Zhou H."/>
        <person name="Jiang X."/>
        <person name="Feng S."/>
        <person name="Jiang X."/>
        <person name="Tian R."/>
        <person name="Wan D."/>
        <person name="Zou H."/>
        <person name="Gu J."/>
      </authorList>
      <dbReference type="PubMed" id="18318008"/>
      <dbReference type="DOI" id="10.1002/pmic.200700884"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-149</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Liver</tissue>
    </source>
  </reference>
  <reference key="22">
    <citation type="journal article" date="2008" name="J. Virol." volume="82" first="10088" last="10101">
      <title>Different types of nsP3-containing protein complexes in Sindbis virus-infected cells.</title>
      <authorList>
        <person name="Gorchakov R."/>
        <person name="Garmashova N."/>
        <person name="Frolova E."/>
        <person name="Frolov I."/>
      </authorList>
      <dbReference type="PubMed" id="18684830"/>
      <dbReference type="DOI" id="10.1128/jvi.01011-08"/>
    </citation>
    <scope>INTERACTION WITH SINBIS VIRUS NON-STRUCTURAL PROTEIN 3 (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="23">
    <citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
      <title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
      <authorList>
        <person name="Gauci S."/>
        <person name="Helbig A.O."/>
        <person name="Slijper M."/>
        <person name="Krijgsveld J."/>
        <person name="Heck A.J."/>
        <person name="Mohammed S."/>
      </authorList>
      <dbReference type="PubMed" id="19413330"/>
      <dbReference type="DOI" id="10.1021/ac9004309"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="24">
    <citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
      <title>Large-scale proteomics analysis of the human kinome.</title>
      <authorList>
        <person name="Oppermann F.S."/>
        <person name="Gnad F."/>
        <person name="Olsen J.V."/>
        <person name="Hornberger R."/>
        <person name="Greff Z."/>
        <person name="Keri G."/>
        <person name="Mann M."/>
        <person name="Daub H."/>
      </authorList>
      <dbReference type="PubMed" id="19369195"/>
      <dbReference type="DOI" id="10.1074/mcp.m800588-mcp200"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="25">
    <citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
      <title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
      <authorList>
        <person name="Mayya V."/>
        <person name="Lundgren D.H."/>
        <person name="Hwang S.-I."/>
        <person name="Rezaul K."/>
        <person name="Wu L."/>
        <person name="Eng J.K."/>
        <person name="Rodionov V."/>
        <person name="Han D.K."/>
      </authorList>
      <dbReference type="PubMed" id="19690332"/>
      <dbReference type="DOI" id="10.1126/scisignal.2000007"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-232</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Leukemic T-cell</tissue>
    </source>
  </reference>
  <reference key="26">
    <citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
      <title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
      <authorList>
        <person name="Choudhary C."/>
        <person name="Kumar C."/>
        <person name="Gnad F."/>
        <person name="Nielsen M.L."/>
        <person name="Rehman M."/>
        <person name="Walther T.C."/>
        <person name="Olsen J.V."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="19608861"/>
      <dbReference type="DOI" id="10.1126/science.1175371"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-376</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="27">
    <citation type="journal article" date="2010" name="Biochem. J." volume="427" first="349" last="357">
      <title>The pseudophosphatase MK-STYX interacts with G3BP and decreases stress granule formation.</title>
      <authorList>
        <person name="Hinton S.D."/>
        <person name="Myers M.P."/>
        <person name="Roggero V.R."/>
        <person name="Allison L.A."/>
        <person name="Tonks N.K."/>
      </authorList>
      <dbReference type="PubMed" id="20180778"/>
      <dbReference type="DOI" id="10.1042/bj20091383"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH STYXL1</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="28">
    <citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
      <title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
      <authorList>
        <person name="Olsen J.V."/>
        <person name="Vermeulen M."/>
        <person name="Santamaria A."/>
        <person name="Kumar C."/>
        <person name="Miller M.L."/>
        <person name="Jensen L.J."/>
        <person name="Gnad F."/>
        <person name="Cox J."/>
        <person name="Jensen T.S."/>
        <person name="Nigg E.A."/>
        <person name="Brunak S."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="20068231"/>
      <dbReference type="DOI" id="10.1126/scisignal.2000475"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-149; SER-232 AND SER-373</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="29">
    <citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
      <title>Initial characterization of the human central proteome.</title>
      <authorList>
        <person name="Burkard T.R."/>
        <person name="Planyavsky M."/>
        <person name="Kaupe I."/>
        <person name="Breitwieser F.P."/>
        <person name="Buerckstuemmer T."/>
        <person name="Bennett K.L."/>
        <person name="Superti-Furga G."/>
        <person name="Colinge J."/>
      </authorList>
      <dbReference type="PubMed" id="21269460"/>
      <dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="30">
    <citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
      <title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
      <authorList>
        <person name="Rigbolt K.T."/>
        <person name="Prokhorova T.A."/>
        <person name="Akimov V."/>
        <person name="Henningsen J."/>
        <person name="Johansen P.T."/>
        <person name="Kratchmarova I."/>
        <person name="Kassem M."/>
        <person name="Mann M."/>
        <person name="Olsen J.V."/>
        <person name="Blagoev B."/>
      </authorList>
      <dbReference type="PubMed" id="21406692"/>
      <dbReference type="DOI" id="10.1126/scisignal.2001570"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-149 AND SER-232</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="31">
    <citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E50134" last="E50134">
      <title>Ataxin-2-like is a regulator of stress granules and processing bodies.</title>
      <authorList>
        <person name="Kaehler C."/>
        <person name="Isensee J."/>
        <person name="Nonhoff U."/>
        <person name="Terrey M."/>
        <person name="Hucho T."/>
        <person name="Lehrach H."/>
        <person name="Krobitsch S."/>
      </authorList>
      <dbReference type="PubMed" id="23209657"/>
      <dbReference type="DOI" id="10.1371/journal.pone.0050134"/>
    </citation>
    <scope>INTERACTION WITH ATXN2L</scope>
  </reference>
  <reference key="32">
    <citation type="journal article" date="2012" name="Mol. Biol. Cell" volume="23" first="4701" last="4712">
      <title>Sequestration of G3BP coupled with efficient translation inhibits stress granules in Semliki Forest virus infection.</title>
      <authorList>
        <person name="Panas M.D."/>
        <person name="Varjak M."/>
        <person name="Lulla A."/>
        <person name="Eng K.E."/>
        <person name="Merits A."/>
        <person name="Karlsson Hedestam G.B."/>
        <person name="McInerney G.M."/>
      </authorList>
      <dbReference type="PubMed" id="23087212"/>
      <dbReference type="DOI" id="10.1091/mbc.e12-08-0619"/>
    </citation>
    <scope>INTERACTION WITH SEMLIKI FOREST VIRUS NON-STRUCTURAL PROTEIN 3 (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="33">
    <citation type="journal article" date="2013" name="Cell" volume="154" first="859" last="874">
      <title>Inhibition of mTORC1 by astrin and stress granules prevents apoptosis in cancer cells.</title>
      <authorList>
        <person name="Thedieck K."/>
        <person name="Holzwarth B."/>
        <person name="Prentzell M.T."/>
        <person name="Boehlke C."/>
        <person name="Klasener K."/>
        <person name="Ruf S."/>
        <person name="Sonntag A.G."/>
        <person name="Maerz L."/>
        <person name="Grellscheid S.N."/>
        <person name="Kremmer E."/>
        <person name="Nitschke R."/>
        <person name="Kuehn E.W."/>
        <person name="Jonker J.W."/>
        <person name="Groen A.K."/>
        <person name="Reth M."/>
        <person name="Hall M.N."/>
        <person name="Baumeister R."/>
      </authorList>
      <dbReference type="PubMed" id="23953116"/>
      <dbReference type="DOI" id="10.1016/j.cell.2013.07.031"/>
    </citation>
    <scope>INTERACTION WITH RPTOR AND SPAG5</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="34">
    <citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
      <title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
      <authorList>
        <person name="Zhou H."/>
        <person name="Di Palma S."/>
        <person name="Preisinger C."/>
        <person name="Peng M."/>
        <person name="Polat A.N."/>
        <person name="Heck A.J."/>
        <person name="Mohammed S."/>
      </authorList>
      <dbReference type="PubMed" id="23186163"/>
      <dbReference type="DOI" id="10.1021/pr300630k"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-149; SER-250 AND SER-253</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
      <tissue>Erythroleukemia</tissue>
    </source>
  </reference>
  <reference key="35">
    <citation type="journal article" date="2013" name="Genes Cells" volume="18" first="135" last="146">
      <title>Both G3BP1 and G3BP2 contribute to stress granule formation.</title>
      <authorList>
        <person name="Matsuki H."/>
        <person name="Takahashi M."/>
        <person name="Higuchi M."/>
        <person name="Makokha G.N."/>
        <person name="Oie M."/>
        <person name="Fujii M."/>
      </authorList>
      <dbReference type="PubMed" id="23279204"/>
      <dbReference type="DOI" id="10.1111/gtc.12023"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH G3BP2; USP10 AND PABPC1</scope>
  </reference>
  <reference key="36">
    <citation type="journal article" date="2013" name="J. Virol." volume="87" first="9511" last="9522">
      <title>Encephalomyocarditis virus disrupts stress granules, the critical platform for triggering antiviral innate immune responses.</title>
      <authorList>
        <person name="Ng C.S."/>
        <person name="Jogi M."/>
        <person name="Yoo J.S."/>
        <person name="Onomoto K."/>
        <person name="Koike S."/>
        <person name="Iwasaki T."/>
        <person name="Yoneyama M."/>
        <person name="Kato H."/>
        <person name="Fujita T."/>
      </authorList>
      <dbReference type="PubMed" id="23785203"/>
      <dbReference type="DOI" id="10.1128/jvi.03248-12"/>
    </citation>
    <scope>PROTEOLYTIC CLEAVAGE (MICROBIAL INFECTION)</scope>
    <scope>MUTAGENESIS OF GLN-325</scope>
  </reference>
  <reference key="37">
    <citation type="journal article" date="2014" name="J. Virol." volume="88" first="5888" last="5893">
      <title>The C-terminal repeat domains of nsP3 from the Old World alphaviruses bind directly to G3BP.</title>
      <authorList>
        <person name="Panas M.D."/>
        <person name="Ahola T."/>
        <person name="McInerney G.M."/>
      </authorList>
      <dbReference type="PubMed" id="24623412"/>
      <dbReference type="DOI" id="10.1128/jvi.00439-14"/>
    </citation>
    <scope>INTERACTION WITH SEMLIKI FOREST VIRUS NON-STRUCTURAL PROTEIN 3 (MICROBIAL INFECTION)</scope>
    <scope>INTERACTION WITH CHIKUNGUNYA VIRUS NON-STRUCTURAL PROTEIN 3 (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="38">
    <citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
      <title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
      <authorList>
        <person name="Bian Y."/>
        <person name="Song C."/>
        <person name="Cheng K."/>
        <person name="Dong M."/>
        <person name="Wang F."/>
        <person name="Huang J."/>
        <person name="Sun D."/>
        <person name="Wang L."/>
        <person name="Ye M."/>
        <person name="Zou H."/>
      </authorList>
      <dbReference type="PubMed" id="24275569"/>
      <dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-149 AND SER-232</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Liver</tissue>
    </source>
  </reference>
  <reference key="39">
    <citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
      <title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
      <authorList>
        <person name="Guo A."/>
        <person name="Gu H."/>
        <person name="Zhou J."/>
        <person name="Mulhern D."/>
        <person name="Wang Y."/>
        <person name="Lee K.A."/>
        <person name="Yang V."/>
        <person name="Aguiar M."/>
        <person name="Kornhauser J."/>
        <person name="Jia X."/>
        <person name="Ren J."/>
        <person name="Beausoleil S.A."/>
        <person name="Silva J.C."/>
        <person name="Vemulapalli V."/>
        <person name="Bedford M.T."/>
        <person name="Comb M.J."/>
      </authorList>
      <dbReference type="PubMed" id="24129315"/>
      <dbReference type="DOI" id="10.1074/mcp.o113.027870"/>
    </citation>
    <scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-429; ARG-435; ARG-447; ARG-460 AND ARG-465</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Colon carcinoma</tissue>
    </source>
  </reference>
  <reference key="40">
    <citation type="journal article" date="2015" name="PLoS Pathog." volume="11" first="E1004659" last="E1004659">
      <title>Viral and cellular proteins containing FGDF motifs bind G3BP to block stress granule formation.</title>
      <authorList>
        <person name="Panas M.D."/>
        <person name="Schulte T."/>
        <person name="Thaa B."/>
        <person name="Sandalova T."/>
        <person name="Kedersha N."/>
        <person name="Achour A."/>
        <person name="McInerney G.M."/>
      </authorList>
      <dbReference type="PubMed" id="25658430"/>
      <dbReference type="DOI" id="10.1371/journal.ppat.1004659"/>
    </citation>
    <scope>INTERACTION WITH SEMLIKI FOREST VIRUS NON-STRUCTURAL PROTEIN 3 (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="41">
    <citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
      <title>N-terminome analysis of the human mitochondrial proteome.</title>
      <authorList>
        <person name="Vaca Jacome A.S."/>
        <person name="Rabilloud T."/>
        <person name="Schaeffer-Reiss C."/>
        <person name="Rompais M."/>
        <person name="Ayoub D."/>
        <person name="Lane L."/>
        <person name="Bairoch A."/>
        <person name="Van Dorsselaer A."/>
        <person name="Carapito C."/>
      </authorList>
      <dbReference type="PubMed" id="25944712"/>
      <dbReference type="DOI" id="10.1002/pmic.201400617"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="42">
    <citation type="journal article" date="2016" name="J. Cell Biol." volume="212" first="845" last="860">
      <title>G3BP-Caprin1-USP10 complexes mediate stress granule condensation and associate with 40S subunits.</title>
      <authorList>
        <person name="Kedersha N."/>
        <person name="Panas M.D."/>
        <person name="Achorn C.A."/>
        <person name="Lyons S."/>
        <person name="Tisdale S."/>
        <person name="Hickman T."/>
        <person name="Thomas M."/>
        <person name="Lieberman J."/>
        <person name="McInerney G.M."/>
        <person name="Ivanov P."/>
        <person name="Anderson P."/>
      </authorList>
      <dbReference type="PubMed" id="27022092"/>
      <dbReference type="DOI" id="10.1083/jcb.201508028"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>INTERACTION WITH 40S RIBOSOME; USP10 AND CAPRIN1</scope>
    <scope>MUTAGENESIS OF PHE-33</scope>
  </reference>
  <reference key="43">
    <citation type="journal article" date="2016" name="Open Biol." volume="6">
      <title>Combined structural, biochemical and cellular evidence demonstrates that both FGDF motifs in alphavirus nsP3 are required for efficient replication.</title>
      <authorList>
        <person name="Schulte T."/>
        <person name="Liu L."/>
        <person name="Panas M.D."/>
        <person name="Thaa B."/>
        <person name="Dickson N."/>
        <person name="Gotte B."/>
        <person name="Achour A."/>
        <person name="McInerney G.M."/>
      </authorList>
      <dbReference type="PubMed" id="27383630"/>
      <dbReference type="DOI" id="10.1098/rsob.160078"/>
    </citation>
    <scope>INTERACTION WITH SEMLIKI FOREST VIRUS NON-STRUCTURAL PROTEIN 3 (MICROBIAL INFECTION)</scope>
    <scope>INTERACTION WITH CHIKUNGUNYA VIRUS NON-STRUCTURAL PROTEIN 3 (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="44">
    <citation type="journal article" date="2017" name="J. Virol." volume="91">
      <title>Mammalian Orthoreovirus Factories Modulate Stress Granule Protein Localization by Interaction with G3BP1.</title>
      <authorList>
        <person name="Choudhury P."/>
        <person name="Bussiere L.D."/>
        <person name="Miller C.L."/>
      </authorList>
      <dbReference type="PubMed" id="28794026"/>
      <dbReference type="DOI" id="10.1128/jvi.01298-17"/>
    </citation>
    <scope>INTERACTION WITH REOVIRUS TYPE 2 PROTEIN SIGMA-NS (MICROBIAL INFECTION)</scope>
    <scope>SUBCELLULAR LOCATION (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="45">
    <citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
      <title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
      <authorList>
        <person name="Hendriks I.A."/>
        <person name="Lyon D."/>
        <person name="Young C."/>
        <person name="Jensen L.J."/>
        <person name="Vertegaal A.C."/>
        <person name="Nielsen M.L."/>
      </authorList>
      <dbReference type="PubMed" id="28112733"/>
      <dbReference type="DOI" id="10.1038/nsmb.3366"/>
    </citation>
    <scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-376</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="46">
    <citation type="journal article" date="2017" name="J. Virol.">
      <title>Zika virus hijacks stress granule proteins and modulates the host stress response.</title>
      <authorList>
        <person name="Hou S."/>
        <person name="Kumar A."/>
        <person name="Xu Z."/>
        <person name="Airo A.M."/>
        <person name="Stryapunina I."/>
        <person name="Wong C.P."/>
        <person name="Branton W."/>
        <person name="Tchesnokov E."/>
        <person name="Goette M."/>
        <person name="Power C."/>
        <person name="Hobman T.C."/>
      </authorList>
      <dbReference type="PubMed" id="28592527"/>
      <dbReference type="DOI" id="10.1128/jvi.00474-17"/>
    </citation>
    <scope>INTERACTION WITH ZIKA VIRUS CAPSID PROTEIN C (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="47">
    <citation type="journal article" date="2018" name="Virus Res." volume="255" first="55" last="67">
      <title>Enterovirus 71 inhibits cytoplasmic stress granule formation during the late stage of infection.</title>
      <authorList>
        <person name="Zhang Y."/>
        <person name="Yao L."/>
        <person name="Xu X."/>
        <person name="Han H."/>
        <person name="Li P."/>
        <person name="Zou D."/>
        <person name="Li X."/>
        <person name="Zheng L."/>
        <person name="Cheng L."/>
        <person name="Shen Y."/>
        <person name="Wang X."/>
        <person name="Wu X."/>
        <person name="Xu J."/>
        <person name="Song B."/>
        <person name="Xu S."/>
        <person name="Zhang H."/>
        <person name="Cao H."/>
      </authorList>
      <dbReference type="PubMed" id="30006004"/>
      <dbReference type="DOI" id="10.1016/j.virusres.2018.07.006"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>MUTAGENESIS OF GLN-325</scope>
    <scope>CLEAVAGE BY HUMAN ENTEROVIRUS 71 PROTEASE 3C (MICROBIAL INFECTION)</scope>
    <scope>CLEAVAGE SITE</scope>
  </reference>
  <reference key="48">
    <citation type="journal article" date="2019" name="J. Virol." volume="93">
      <title>Foot-and-Mouth Disease Virus Leader Protease Cleaves G3BP1 and G3BP2 and Inhibits Stress Granule Formation.</title>
      <authorList>
        <person name="Visser L.J."/>
        <person name="Medina G.N."/>
        <person name="Rabouw H.H."/>
        <person name="de Groot R.J."/>
        <person name="Langereis M.A."/>
        <person name="de Los Santos T."/>
        <person name="van Kuppeveld F.J.M."/>
      </authorList>
      <dbReference type="PubMed" id="30404792"/>
      <dbReference type="DOI" id="10.1128/jvi.00922-18"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>CLEAVAGE BY FOOT-AND-MOUTH DISEASE VIRUS LEADER PROTEASE (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="49">
    <citation type="journal article" date="2019" name="Nat. Immunol." volume="20" first="18" last="28">
      <title>G3BP1 promotes DNA binding and activation of cGAS.</title>
      <authorList>
        <person name="Liu Z.S."/>
        <person name="Cai H."/>
        <person name="Xue W."/>
        <person name="Wang M."/>
        <person name="Xia T."/>
        <person name="Li W.J."/>
        <person name="Xing J.Q."/>
        <person name="Zhao M."/>
        <person name="Huang Y.J."/>
        <person name="Chen S."/>
        <person name="Wu S.M."/>
        <person name="Wang X."/>
        <person name="Liu X."/>
        <person name="Pang X."/>
        <person name="Zhang Z.Y."/>
        <person name="Li T."/>
        <person name="Dai J."/>
        <person name="Dong F."/>
        <person name="Xia Q."/>
        <person name="Li A.L."/>
        <person name="Zhou T."/>
        <person name="Liu Z.G."/>
        <person name="Zhang X.M."/>
        <person name="Li T."/>
      </authorList>
      <dbReference type="PubMed" id="30510222"/>
      <dbReference type="DOI" id="10.1038/s41590-018-0262-4"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>INTERACTION WITH CGAS</scope>
  </reference>
  <reference key="50">
    <citation type="journal article" date="2019" name="J. Biol. Chem." volume="294" first="6430" last="6438">
      <title>The stress granule protein G3BP1 binds viral dsRNA and RIG-I to enhance IFN-beta response.</title>
      <authorList>
        <person name="Kim S.S."/>
        <person name="Sze L."/>
        <person name="Lam K.P."/>
      </authorList>
      <dbReference type="PubMed" id="30804210"/>
      <dbReference type="DOI" id="10.1074/jbc.ra118.005868"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH RIGI</scope>
  </reference>
  <reference key="51">
    <citation type="journal article" date="2020" name="Cell" volume="181" first="306" last="324">
      <title>Competing protein-RNA interaction networks control multiphase intracellular organization.</title>
      <authorList>
        <person name="Sanders D.W."/>
        <person name="Kedersha N."/>
        <person name="Lee D.S.W."/>
        <person name="Strom A.R."/>
        <person name="Drake V."/>
        <person name="Riback J.A."/>
        <person name="Bracha D."/>
        <person name="Eeftens J.M."/>
        <person name="Iwanicki A."/>
        <person name="Wang A."/>
        <person name="Wei M.T."/>
        <person name="Whitney G."/>
        <person name="Lyons S.M."/>
        <person name="Anderson P."/>
        <person name="Jacobs W.M."/>
        <person name="Ivanov P."/>
        <person name="Brangwynne C.P."/>
      </authorList>
      <dbReference type="PubMed" id="32302570"/>
      <dbReference type="DOI" id="10.1016/j.cell.2020.03.050"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>ACTIVITY REGULATION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>DOMAIN</scope>
    <scope>INTERACTION WITH CAPRIN1; USP10 AND UBAP2L</scope>
  </reference>
  <reference key="52">
    <citation type="journal article" date="2020" name="Cell" volume="181" first="325" last="345">
      <title>G3BP1 is a tunable switch that triggers phase separation to assemble stress granules.</title>
      <authorList>
        <person name="Yang P."/>
        <person name="Mathieu C."/>
        <person name="Kolaitis R.M."/>
        <person name="Zhang P."/>
        <person name="Messing J."/>
        <person name="Yurtsever U."/>
        <person name="Yang Z."/>
        <person name="Wu J."/>
        <person name="Li Y."/>
        <person name="Pan Q."/>
        <person name="Yu J."/>
        <person name="Martin E.W."/>
        <person name="Mittag T."/>
        <person name="Kim H.J."/>
        <person name="Taylor J.P."/>
      </authorList>
      <dbReference type="PubMed" id="32302571"/>
      <dbReference type="DOI" id="10.1016/j.cell.2020.03.046"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>ACTIVITY REGULATION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>DOMAIN</scope>
    <scope>INTERACTION WITH CAPRIN1</scope>
    <scope>PHOSPHORYLATION AT SER-149</scope>
    <scope>MUTAGENESIS OF PHE-33; SER-149 AND 380-PHE--PHE-382</scope>
  </reference>
  <reference key="53">
    <citation type="journal article" date="2020" name="Cell" volume="181" first="346" last="361">
      <title>RNA-Induced conformational switching and clustering of G3BP drive stress granule assembly by condensation.</title>
      <authorList>
        <person name="Guillen-Boixet J."/>
        <person name="Kopach A."/>
        <person name="Holehouse A.S."/>
        <person name="Wittmann S."/>
        <person name="Jahnel M."/>
        <person name="Schluessler R."/>
        <person name="Kim K."/>
        <person name="Trussina I.R.E.A."/>
        <person name="Wang J."/>
        <person name="Mateju D."/>
        <person name="Poser I."/>
        <person name="Maharana S."/>
        <person name="Ruer-Gruss M."/>
        <person name="Richter D."/>
        <person name="Zhang X."/>
        <person name="Chang Y.T."/>
        <person name="Guck J."/>
        <person name="Honigmann A."/>
        <person name="Mahamid J."/>
        <person name="Hyman A.A."/>
        <person name="Pappu R.V."/>
        <person name="Alberti S."/>
        <person name="Franzmann T.M."/>
      </authorList>
      <dbReference type="PubMed" id="32302572"/>
      <dbReference type="DOI" id="10.1016/j.cell.2020.03.049"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>ACTIVITY REGULATION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>DOMAIN</scope>
    <scope>INTERACTION WITH CAPRIN1</scope>
    <scope>PHOSPHORYLATION AT SER-149 AND SER-232</scope>
    <scope>MUTAGENESIS OF SER-149 AND SER-232</scope>
  </reference>
  <reference key="54">
    <citation type="journal article" date="2020" name="Mol. Cell" volume="77" first="1193" last="1205">
      <title>The G3BP1-family-USP10 deubiquitinase complex rescues ubiquitinated 40S subunits of ribosomes stalled in translation from lysosomal degradation.</title>
      <authorList>
        <person name="Meyer C."/>
        <person name="Garzia A."/>
        <person name="Morozov P."/>
        <person name="Molina H."/>
        <person name="Tuschl T."/>
      </authorList>
      <dbReference type="PubMed" id="31981475"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2019.12.024"/>
    </citation>
    <scope>INTERACTION WITH USP10</scope>
  </reference>
  <reference key="55">
    <citation type="journal article" date="2021" name="Science" volume="372" first="eabf6548" last="eabf6548">
      <title>Ubiquitination of G3BP1 mediates stress granule disassembly in a context-specific manner.</title>
      <authorList>
        <person name="Gwon Y."/>
        <person name="Maxwell B.A."/>
        <person name="Kolaitis R.M."/>
        <person name="Zhang P."/>
        <person name="Kim H.J."/>
        <person name="Taylor J.P."/>
      </authorList>
      <dbReference type="PubMed" id="34739333"/>
      <dbReference type="DOI" id="10.1126/science.abf6548"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>UBIQUITINATION AT LYS-36; LYS-50; LYS-59; LYS-64; LYS-76; LYS-123; LYS-353; LYS-357; LYS-376 AND LYS-393</scope>
    <scope>MUTAGENESIS OF LYS-36; LYS-50; LYS-59; LYS-64; LYS-76; LYS-123; LYS-353; LYS-357; LYS-376 AND LYS-393</scope>
  </reference>
  <reference key="56">
    <citation type="journal article" date="2022" name="EMBO Rep." volume="23" first="e53166" last="e53166">
      <title>The stress granule protein G3BP1 promotes pre-condensation of cGAS to allow rapid responses to DNA.</title>
      <authorList>
        <person name="Zhao M."/>
        <person name="Xia T."/>
        <person name="Xing J.Q."/>
        <person name="Yin L.H."/>
        <person name="Li X.W."/>
        <person name="Pan J."/>
        <person name="Liu J.Y."/>
        <person name="Sun L.M."/>
        <person name="Wang M."/>
        <person name="Li T."/>
        <person name="Mao J."/>
        <person name="Han Q.Y."/>
        <person name="Xue W."/>
        <person name="Cai H."/>
        <person name="Wang K."/>
        <person name="Xu X."/>
        <person name="Li T."/>
        <person name="He K."/>
        <person name="Wang N."/>
        <person name="Li A.L."/>
        <person name="Zhou T."/>
        <person name="Zhang X.M."/>
        <person name="Li W.H."/>
        <person name="Li T."/>
      </authorList>
      <dbReference type="PubMed" id="34779554"/>
      <dbReference type="DOI" id="10.15252/embr.202153166"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH CGAS</scope>
  </reference>
  <reference key="57">
    <citation type="journal article" date="2023" name="Autophagy" volume="19" first="1934" last="1951">
      <title>Stress granule homeostasis is modulated by TRIM21-mediated ubiquitination of G3BP1 and autophagy-dependent elimination of stress granules.</title>
      <authorList>
        <person name="Yang C."/>
        <person name="Wang Z."/>
        <person name="Kang Y."/>
        <person name="Yi Q."/>
        <person name="Wang T."/>
        <person name="Bai Y."/>
        <person name="Liu Y."/>
      </authorList>
      <dbReference type="PubMed" id="36692217"/>
      <dbReference type="DOI" id="10.1080/15548627.2022.2164427"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>UBIQUITINATION</scope>
  </reference>
  <reference key="58">
    <citation type="journal article" date="2023" name="Cell">
      <title>QKI shuttles internal m7G-modified transcripts into stress granules and modulates mRNA metabolism.</title>
      <authorList>
        <person name="Zhao Z."/>
        <person name="Qing Y."/>
        <person name="Dong L."/>
        <person name="Han L."/>
        <person name="Wu D."/>
        <person name="Li Y."/>
        <person name="Li W."/>
        <person name="Xue J."/>
        <person name="Zhou K."/>
        <person name="Sun M."/>
        <person name="Tan B."/>
        <person name="Chen Z."/>
        <person name="Shen C."/>
        <person name="Gao L."/>
        <person name="Small A."/>
        <person name="Wang K."/>
        <person name="Leung K."/>
        <person name="Zhang Z."/>
        <person name="Qin X."/>
        <person name="Deng X."/>
        <person name="Xia Q."/>
        <person name="Su R."/>
        <person name="Chen J."/>
      </authorList>
      <dbReference type="PubMed" id="37379838"/>
      <dbReference type="DOI" id="10.1016/j.cell.2023.05.047"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH QKI</scope>
  </reference>
  <reference key="59">
    <citation type="journal article" date="2022" name="Sci. Adv." volume="8" first="eabo7112" last="eabo7112">
      <title>De novo variants in genes regulating stress granule assembly associate with neurodevelopmental disorders.</title>
      <authorList>
        <person name="Jia X."/>
        <person name="Zhang S."/>
        <person name="Tan S."/>
        <person name="Du B."/>
        <person name="He M."/>
        <person name="Qin H."/>
        <person name="Chen J."/>
        <person name="Duan X."/>
        <person name="Luo J."/>
        <person name="Chen F."/>
        <person name="Ouyang L."/>
        <person name="Wang J."/>
        <person name="Chen G."/>
        <person name="Yu B."/>
        <person name="Zhang G."/>
        <person name="Zhang Z."/>
        <person name="Lyu Y."/>
        <person name="Huang Y."/>
        <person name="Jiao J."/>
        <person name="Chen J.Y.H."/>
        <person name="Swoboda K.J."/>
        <person name="Agolini E."/>
        <person name="Novelli A."/>
        <person name="Leoni C."/>
        <person name="Zampino G."/>
        <person name="Cappuccio G."/>
        <person name="Brunetti-Pierri N."/>
        <person name="Gerard B."/>
        <person name="Ginglinger E."/>
        <person name="Richer J."/>
        <person name="McMillan H."/>
        <person name="White-Brown A."/>
        <person name="Hoekzema K."/>
        <person name="Bernier R.A."/>
        <person name="Kurtz-Nelson E.C."/>
        <person name="Earl R.K."/>
        <person name="Meddens C."/>
        <person name="Alders M."/>
        <person name="Fuchs M."/>
        <person name="Caumes R."/>
        <person name="Brunelle P."/>
        <person name="Smol T."/>
        <person name="Kuehl R."/>
        <person name="Day-Salvatore D.L."/>
        <person name="Monaghan K.G."/>
        <person name="Morrow M.M."/>
        <person name="Eichler E.E."/>
        <person name="Hu Z."/>
        <person name="Yuan L."/>
        <person name="Tan J."/>
        <person name="Xia K."/>
        <person name="Shen Y."/>
        <person name="Guo H."/>
      </authorList>
      <dbReference type="PubMed" id="35977029"/>
      <dbReference type="DOI" id="10.1126/sciadv.abo7112"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>VARIANTS CYS-78; ILE-132; CYS-208; CYS-320 AND MET-366</scope>
    <scope>CHARACTERIZATION OF VARIANTS CYS-78; ILE-132; CYS-208; CYS-320 AND MET-366</scope>
  </reference>
  <reference key="60">
    <citation type="submission" date="2011-02" db="PDB data bank">
      <title>Crystal structure of the NTF2 domain of ras GTPase-activating protein-binding protein 1.</title>
      <authorList>
        <consortium name="Structural genomics consortium (SGC)"/>
      </authorList>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 1-139</scope>
  </reference>
  <reference key="61">
    <citation type="journal article" date="2013" name="PLoS ONE" volume="8" first="E80947" last="E80947">
      <title>Crystal structures of the human G3BP1 NTF2-like domain visualize FxFG Nup repeat specificity.</title>
      <authorList>
        <person name="Vognsen T."/>
        <person name="Moeller I.R."/>
        <person name="Kristensen O."/>
      </authorList>
      <dbReference type="PubMed" id="24324649"/>
      <dbReference type="DOI" id="10.1371/journal.pone.0080947"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (1.62 ANGSTROMS) OF 1-139</scope>
    <scope>SUBUNIT</scope>
  </reference>
  <reference evidence="46" key="62">
    <citation type="journal article" date="2022" name="J. Biol. Chem." volume="298" first="102552" last="102552">
      <title>Tryptophan mutations in G3BP1 tune the stability of a cellular signaling hub by weakening transient interactions with Caprin1 and USP10.</title>
      <authorList>
        <person name="Sheehan C.T."/>
        <person name="Hampton T.H."/>
        <person name="Madden D.R."/>
      </authorList>
      <dbReference type="PubMed" id="36183834"/>
      <dbReference type="DOI" id="10.1016/j.jbc.2022.102552"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.36 ANGSTROMS) OF 1-138</scope>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH CAPRIN1 AND USP10</scope>
    <scope>MUTAGENESIS OF PHE-15; PHE-33 AND PHE-124</scope>
  </reference>
  <reference key="63">
    <citation type="journal article" date="2022" name="Proc. Natl. Acad. Sci. U.S.A." volume="119" first="e2207975119" last="e2207975119">
      <title>Yin and yang regulation of stress granules by Caprin-1.</title>
      <authorList>
        <person name="Song D."/>
        <person name="Kuang L."/>
        <person name="Yang L."/>
        <person name="Wang L."/>
        <person name="Li H."/>
        <person name="Li X."/>
        <person name="Zhu Z."/>
        <person name="Shi C."/>
        <person name="Zhu H."/>
        <person name="Gong W."/>
      </authorList>
      <dbReference type="PubMed" id="36279435"/>
      <dbReference type="DOI" id="10.1073/pnas.2207975119"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.46 ANGSTROMS) OF 1-139 IN COMPLEX WITH USP10 AND CAPRIN1</scope>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH CAPRIN1 AND USP10</scope>
  </reference>
  <comment type="function">
    <text evidence="6 7 10 13 19 25 26 28 29 30 31 32 33 34 35 36 37 39">Protein involved in various processes, such as stress granule formation and innate immunity (PubMed:12642610, PubMed:20180778, PubMed:23279204, PubMed:30510222, PubMed:30804210). Plays an essential role in stress granule formation (PubMed:12642610, PubMed:20180778, PubMed:23279204, PubMed:32302570, PubMed:32302571, PubMed:32302572, PubMed:34739333, PubMed:35977029, PubMed:36183834, PubMed:36279435, PubMed:36692217, PubMed:37379838). Stress granules are membraneless compartments that store mRNAs and proteins, such as stalled translation pre-initiation complexes, in response to stress (PubMed:12642610, PubMed:20180778, PubMed:23279204, PubMed:27022092, PubMed:32302570, PubMed:32302571, PubMed:32302572, PubMed:36279435, PubMed:37379838). Promotes formation of stress granules phase-separated membraneless compartment by undergoing liquid-liquid phase separation (LLPS) upon unfolded RNA-binding: functions as a molecular switch that triggers RNA-dependent LLPS in response to a rise in intracellular free RNA concentrations (PubMed:32302570, PubMed:32302571, PubMed:32302572, PubMed:34739333, PubMed:36279435, PubMed:36692217). Also acts as an ATP- and magnesium-dependent helicase: unwinds DNA/DNA, RNA/DNA, and RNA/RNA substrates with comparable efficiency (PubMed:9889278). Acts unidirectionally by moving in the 5' to 3' direction along the bound single-stranded DNA (PubMed:9889278). Unwinds preferentially partial DNA and RNA duplexes having a 17 bp annealed portion and either a hanging 3' tail or hanging tails at both 5'- and 3'-ends (PubMed:9889278). Plays an essential role in innate immunity by promoting CGAS and RIGI activity (PubMed:30510222, PubMed:30804210). Participates in the DNA-triggered cGAS/STING pathway by promoting the DNA binding and activation of CGAS (PubMed:30510222). Triggers the condensation of cGAS, a process probably linked to the formation of membrane-less organelles (PubMed:34779554). Enhances also RIGI-induced type I interferon production probably by helping RIGI at sensing pathogenic RNA (PubMed:30804210). May also act as a phosphorylation-dependent sequence-specific endoribonuclease in vitro: Cleaves exclusively between cytosine and adenine and cleaves MYC mRNA preferentially at the 3'-UTR (PubMed:11604510).</text>
  </comment>
  <comment type="catalytic activity">
    <reaction evidence="39">
      <text>ATP + H2O = ADP + H(+) + phosphate</text>
      <dbReference type="Rhea" id="RHEA:13065"/>
      <dbReference type="ChEBI" id="CHEBI:15377"/>
      <dbReference type="ChEBI" id="CHEBI:15378"/>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
      <dbReference type="ChEBI" id="CHEBI:43474"/>
      <dbReference type="ChEBI" id="CHEBI:456216"/>
      <dbReference type="EC" id="3.6.4.12"/>
    </reaction>
  </comment>
  <comment type="catalytic activity">
    <reaction evidence="39">
      <text>ATP + H2O = ADP + H(+) + phosphate</text>
      <dbReference type="Rhea" id="RHEA:13065"/>
      <dbReference type="ChEBI" id="CHEBI:15377"/>
      <dbReference type="ChEBI" id="CHEBI:15378"/>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
      <dbReference type="ChEBI" id="CHEBI:43474"/>
      <dbReference type="ChEBI" id="CHEBI:456216"/>
      <dbReference type="EC" id="3.6.4.13"/>
    </reaction>
  </comment>
  <comment type="cofactor">
    <cofactor evidence="39">
      <name>Mg(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:18420"/>
    </cofactor>
    <text evidence="39">Mg(2+) is required for helicase activity.</text>
  </comment>
  <comment type="activity regulation">
    <text evidence="28 29 30">Under physiological conditions, G3BP1 adopts a compact state that is stabilized by intramolecular interactions between the RG-rich and the acidic regions that inhibit phase separation (PubMed:32302570, PubMed:32302571, PubMed:32302572). Upon stress, polysomes disassemble and mRNAs are released in an unfolded protein-free state (PubMed:32302570, PubMed:32302571, PubMed:32302572). Binding of unfolded mRNA to G3BP1 outcompetes the intramolecular interactions and RNA-bound G3BP1 adopts an expanded conformation in which the RG-rich region becomes exposed to engage in protein-protein and protein-RNA interactions, allowing physical cross-linking of RNA molecules to form protein-RNA condensates, leading to liquid-liquid phase separation (LLPS) (PubMed:32302570, PubMed:32302571, PubMed:32302572).</text>
  </comment>
  <comment type="subunit">
    <text evidence="1 5 7 8 10 12 13 15 16 19 25 26 27 28 29 30 32 34 35 37">Homodimer and oligomer (PubMed:12642610, PubMed:24324649). Component of a TAU mRNP complex, at least composed of IGF2BP1, ELAVL4 and G3BP1 (By similarity). Binds to the SH3 domain of Ras GTPase-activating protein (RASA1) in proliferating cells (By similarity). No interaction in quiescent cells (By similarity). Interacts (via NTF2 domain) with USP10; inhibiting stress granule formation by lowering G3BP1 valence (PubMed:11439350, PubMed:23279204, PubMed:27022092, PubMed:31981475, PubMed:32302570, PubMed:36183834, PubMed:36279435). Interacts (via NTF2 domain) with CAPRIN1; promoting stress granule formation by lowering the saturation-concentration of G3BP1 (PubMed:17210633, PubMed:27022092, PubMed:32302570, PubMed:32302571, PubMed:32302572, PubMed:36183834, PubMed:36279435). Interacts (via NTF2 domain) with UBAP2L; promoting stress granule formation (PubMed:32302570). Associates (via RG-rich region) with 40S ribosome subunits (PubMed:27022092). Interacts with RPTOR and SPAG5; this complex is increased by oxidative stress (PubMed:23953116). Interacts with ATXN2L (PubMed:23209657). Interacts with STYXL1 (PubMed:20180778). Interacts with CGAS (via N-terminus); this interaction promotes the DNA-binding and activation of CGAS (PubMed:30510222, PubMed:34779554). Interacts (via C-terminus) with RIGI (PubMed:30804210). Interacts with PABPC1 (PubMed:23279204). Interacts with QKI (isoforms QKI6 and QKI7); directing N(7)-methylguanine-containing mRNAs to stress granules (PubMed:37379838).</text>
  </comment>
  <comment type="subunit">
    <text evidence="11 17 18 20">(Microbial infection) Interacts with Semliki forest virus non-structural protein 3 (via C-terminus); this interaction inhibits the formation of stress granules on viral mRNAs and the nsp3-G3BP1 complexes bind viral RNAs and probably orchestrate the assembly of viral replication complexes.</text>
  </comment>
  <comment type="subunit">
    <text evidence="17 18">(Microbial infection) Interacts with Chikungunya virus non-structural protein 3 (via C-terminus); this interaction inhibits the formation of stress granules on viral mRNAs and the nsp3-G3BP1 complexes bind viral RNAs and probably orchestrate the assembly of viral replication complexes.</text>
  </comment>
  <comment type="subunit">
    <text evidence="9">(Microbial infection) Interacts with Sindbis virus non-structural protein 3 (via C-terminus); this interaction inhibits the formation of stress granules on viral mRNAs and the nsp3-G3BP1 complexes bind viral RNAs and probably orchestrate the assembly of viral replication complexes.</text>
  </comment>
  <comment type="subunit">
    <text evidence="21">(Microbial infection) Interacts with Zika virus capsid protein C; this interaction is probably linked to the inhibition of stress granules formation by the virus.</text>
  </comment>
  <comment type="subunit">
    <text evidence="22">(Microbial infection) Interacts with reovirus type 2 protein sigma-NS; this interaction induces the relocalization of G3BP1 to the outer periphery of sigma-NS/mu-Ns viral factories and is probably involved in the suppression of the integrated stress response by the virus.</text>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1047359">
      <id>Q13283</id>
    </interactant>
    <interactant intactId="EBI-697691">
      <id>Q99700</id>
      <label>ATXN2</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>4</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1047359">
      <id>Q13283</id>
    </interactant>
    <interactant intactId="EBI-948363">
      <id>Q8WWM7</id>
      <label>ATXN2L</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>6</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1047359">
      <id>Q13283</id>
    </interactant>
    <interactant intactId="EBI-1047080">
      <id>Q14444</id>
      <label>CAPRIN1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>8</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1047359">
      <id>Q13283</id>
    </interactant>
    <interactant intactId="EBI-742651">
      <id>P35638</id>
      <label>DDIT3</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1047359">
      <id>Q13283</id>
    </interactant>
    <interactant intactId="EBI-366305">
      <id>Q06787</id>
      <label>FMR1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>7</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1047359">
      <id>Q13283</id>
    </interactant>
    <interactant intactId="EBI-466029">
      <id>P42858</id>
      <label>HTT</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>16</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1047359">
      <id>Q13283</id>
    </interactant>
    <interactant intactId="EBI-2862434">
      <id>Q96L73</id>
      <label>NSD1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1047359">
      <id>Q13283</id>
    </interactant>
    <interactant intactId="EBI-1567928">
      <id>Q8N122</id>
      <label>RPTOR</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>4</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1047359">
      <id>Q13283</id>
    </interactant>
    <interactant intactId="EBI-1044112">
      <id>Q7KZF4</id>
      <label>SND1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1047359">
      <id>Q13283</id>
    </interactant>
    <interactant intactId="EBI-2341129">
      <id>Q14258</id>
      <label>TRIM25</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1047359">
      <id>Q13283</id>
    </interactant>
    <interactant intactId="EBI-347762">
      <id>Q14157</id>
      <label>UBAP2L</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1047359">
      <id>Q13283</id>
    </interactant>
    <interactant intactId="EBI-2510389">
      <id>Q14694</id>
      <label>USP10</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>16</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1047359">
      <id>Q13283</id>
    </interactant>
    <interactant intactId="EBI-25592177">
      <id>K9N4V7</id>
      <label>N</label>
    </interactant>
    <organismsDiffer>true</organismsDiffer>
    <experiments>5</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1047359">
      <id>Q13283</id>
    </interactant>
    <interactant intactId="EBI-25475856">
      <id>P0DTC9</id>
      <label>N</label>
    </interactant>
    <organismsDiffer>true</organismsDiffer>
    <experiments>71</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1047359">
      <id>Q13283</id>
    </interactant>
    <interactant intactId="EBI-7602718">
      <id>P59595</id>
      <label>N</label>
    </interactant>
    <organismsDiffer>true</organismsDiffer>
    <experiments>12</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1047359">
      <id>Q13283</id>
    </interactant>
    <interactant intactId="EBI-25475864">
      <id>PRO_0000449623</id>
      <label>rep</label>
      <dbReference type="UniProtKB" id="P0DTD1"/>
    </interactant>
    <organismsDiffer>true</organismsDiffer>
    <experiments>5</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1047359">
      <id>Q13283</id>
    </interactant>
    <interactant intactId="EBI-30810942">
      <id>Q809B7</id>
    </interactant>
    <organismsDiffer>true</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="subcellular location">
    <subcellularLocation>
      <location evidence="10 25">Cytoplasm</location>
      <location evidence="10 25">Cytosol</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="1">Perikaryon</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="7 8 10 15 19 24 28 29 30">Cytoplasm</location>
      <location evidence="7 8 10 15 19 24 28 29 30">Stress granule</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="6">Nucleus</location>
    </subcellularLocation>
    <text evidence="6 7 10">Cytoplasmic in proliferating cells (PubMed:11604510). Cytosolic and partially nuclear in resting cells (PubMed:11604510). Recruited to stress granules in response to arsenite treatment (PubMed:12642610, PubMed:20180778). The unphosphorylated form is recruited to stress granules (PubMed:12642610). HRAS signaling contributes to this process by regulating G3BP dephosphorylation (PubMed:12642610).</text>
  </comment>
  <comment type="alternative products">
    <event type="alternative splicing"/>
    <isoform>
      <id>Q13283-1</id>
      <name>1</name>
      <sequence type="displayed"/>
    </isoform>
    <isoform>
      <id>Q13283-2</id>
      <name>2</name>
      <sequence type="described" ref="VSP_056280 VSP_056281"/>
    </isoform>
  </comment>
  <comment type="tissue specificity">
    <text evidence="38">Ubiquitous.</text>
  </comment>
  <comment type="domain">
    <text evidence="28 29 30">Can mediate both protein-protein and protein-RNA interactions via the NTF2 domain and RNA-binding domain RRM; protein-protein and protein-RNA interactions are essential for undergoing liquid-liquid phase separation (LLPS).</text>
  </comment>
  <comment type="domain">
    <text evidence="28 30">The acidic disordered region acts as a negative regulator of phase separation.</text>
  </comment>
  <comment type="domain">
    <text evidence="28 29">The NTF2 domain mediates interaction with CAPRIN1 and USP10 regulators, thereby regulating assembly of stress granules.</text>
  </comment>
  <comment type="PTM">
    <text evidence="6 7 29 30">Phosphorylation of the acidic disordered region regulates stress granule assembly (PubMed:32302571, PubMed:32302572). RASA1-dependent phosphorylation of Ser-149 induces a conformational change that prevents self-association (PubMed:11604510, PubMed:12642610). Dephosphorylation after HRAS activation is required for stress granule assembly (PubMed:11604510, PubMed:12642610). Ser-149 phosphorylation induces partial nuclear localization (PubMed:11604510).</text>
  </comment>
  <comment type="PTM">
    <text evidence="31 36">Ubiquitinated by TRIM21 via 'Lys-63'-linked polyubiquitination in the NTF2 domain in response to heat shock, leading to stress granule disassembly: ubiquitination promotes interaction with the FAF2 adapter, followed by interaction with VCP, which extracts G3BP1 from stress granules, leading to stress granule disassembly (PubMed:34739333, PubMed:36692217). In case of prolonged stress, ubiquitination by TRIM21 leads to autophagy-dependent degradation of G3BP1 via recruitment of ubiquitinated G3BP1 by SQSTM1 and/or CALCOCO2 to autophagosomes (PubMed:34739333, PubMed:36692217).</text>
  </comment>
  <comment type="PTM">
    <text evidence="23 24">(Microbial infection) Cleaved by human enterovirus 71; this cleavage induces the disassembly of cytoplasmic stress granules (PubMed:30006004). Cleaved by Foot-and-mouth disease virus; this cleavage suppresses the formation of cytoplasmic stress granules (PubMed:30404792).</text>
  </comment>
  <comment type="PTM">
    <text>Arg-435 is dimethylated, probably to asymmetric dimethylarginine.</text>
  </comment>
  <comment type="PTM">
    <text evidence="14">(Microbial infection) Cleaved by Encephalomyocarditis virus protease 3C; this cleavage suppresses the formation of cytoplasmic stress granules.</text>
  </comment>
  <dbReference type="EC" id="3.6.4.12" evidence="39"/>
  <dbReference type="EC" id="3.6.4.13" evidence="39"/>
  <dbReference type="EMBL" id="U32519">
    <property type="protein sequence ID" value="AAB07787.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AK300098">
    <property type="protein sequence ID" value="BAG61899.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BX647869">
    <property type="protein sequence ID" value="CAI46065.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AC091982">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC006997">
    <property type="protein sequence ID" value="AAH06997.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS4319.1">
    <molecule id="Q13283-1"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_005745.1">
    <molecule id="Q13283-1"/>
    <property type="nucleotide sequence ID" value="NM_005754.2"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_938405.1">
    <molecule id="Q13283-1"/>
    <property type="nucleotide sequence ID" value="NM_198395.1"/>
  </dbReference>
  <dbReference type="RefSeq" id="XP_006714812.1">
    <property type="nucleotide sequence ID" value="XM_006714749.3"/>
  </dbReference>
  <dbReference type="RefSeq" id="XP_006714813.1">
    <property type="nucleotide sequence ID" value="XM_006714750.3"/>
  </dbReference>
  <dbReference type="RefSeq" id="XP_016864411.1">
    <property type="nucleotide sequence ID" value="XM_017008922.1"/>
  </dbReference>
  <dbReference type="RefSeq" id="XP_016864412.1">
    <property type="nucleotide sequence ID" value="XM_017008923.1"/>
  </dbReference>
  <dbReference type="PDB" id="3Q90">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.70 A"/>
    <property type="chains" value="A/B=1-139"/>
  </dbReference>
  <dbReference type="PDB" id="4FCJ">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.62 A"/>
    <property type="chains" value="A/B=1-139"/>
  </dbReference>
  <dbReference type="PDB" id="4FCM">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.69 A"/>
    <property type="chains" value="A/B=1-139"/>
  </dbReference>
  <dbReference type="PDB" id="4IIA">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.30 A"/>
    <property type="chains" value="A=11-139"/>
  </dbReference>
  <dbReference type="PDB" id="5FW5">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.92 A"/>
    <property type="chains" value="A/B=1-139"/>
  </dbReference>
  <dbReference type="PDB" id="6TA7">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.93 A"/>
    <property type="chains" value="A/B/C/D/E/F=1-139"/>
  </dbReference>
  <dbReference type="PDB" id="7S17">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.36 A"/>
    <property type="chains" value="A/B=1-138"/>
  </dbReference>
  <dbReference type="PDB" id="7SUO">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.35 A"/>
    <property type="chains" value="A/B=2-139"/>
  </dbReference>
  <dbReference type="PDB" id="7XHF">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.68 A"/>
    <property type="chains" value="A/B=1-139"/>
  </dbReference>
  <dbReference type="PDB" id="7XHG">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.46 A"/>
    <property type="chains" value="A/B/C/D=1-139"/>
  </dbReference>
  <dbReference type="PDB" id="8TH1">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.80 A"/>
    <property type="chains" value="A/B/C/D=1-139"/>
  </dbReference>
  <dbReference type="PDB" id="8TH5">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.62 A"/>
    <property type="chains" value="A/B/C/D/E/F/G/H/I/J=1-139"/>
  </dbReference>
  <dbReference type="PDB" id="8TH6">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.34 A"/>
    <property type="chains" value="A/B/C/D=1-139"/>
  </dbReference>
  <dbReference type="PDB" id="8TH7">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.88 A"/>
    <property type="chains" value="A/B=1-139"/>
  </dbReference>
  <dbReference type="PDB" id="8V1L">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.68 A"/>
    <property type="chains" value="A/B/C/D/E/F=1-139"/>
  </dbReference>
  <dbReference type="PDBsum" id="3Q90"/>
  <dbReference type="PDBsum" id="4FCJ"/>
  <dbReference type="PDBsum" id="4FCM"/>
  <dbReference type="PDBsum" id="4IIA"/>
  <dbReference type="PDBsum" id="5FW5"/>
  <dbReference type="PDBsum" id="6TA7"/>
  <dbReference type="PDBsum" id="7S17"/>
  <dbReference type="PDBsum" id="7SUO"/>
  <dbReference type="PDBsum" id="7XHF"/>
  <dbReference type="PDBsum" id="7XHG"/>
  <dbReference type="PDBsum" id="8TH1"/>
  <dbReference type="PDBsum" id="8TH5"/>
  <dbReference type="PDBsum" id="8TH6"/>
  <dbReference type="PDBsum" id="8TH7"/>
  <dbReference type="PDBsum" id="8V1L"/>
  <dbReference type="AlphaFoldDB" id="Q13283"/>
  <dbReference type="SMR" id="Q13283"/>
  <dbReference type="BioGRID" id="115448">
    <property type="interactions" value="838"/>
  </dbReference>
  <dbReference type="CORUM" id="Q13283"/>
  <dbReference type="ELM" id="Q13283"/>
  <dbReference type="IntAct" id="Q13283">
    <property type="interactions" value="383"/>
  </dbReference>
  <dbReference type="MINT" id="Q13283"/>
  <dbReference type="STRING" id="9606.ENSP00000377681"/>
  <dbReference type="GlyCosmos" id="Q13283">
    <property type="glycosylation" value="3 sites, 1 glycan"/>
  </dbReference>
  <dbReference type="GlyGen" id="Q13283">
    <property type="glycosylation" value="8 sites, 1 O-linked glycan (8 sites)"/>
  </dbReference>
  <dbReference type="iPTMnet" id="Q13283"/>
  <dbReference type="MetOSite" id="Q13283"/>
  <dbReference type="PhosphoSitePlus" id="Q13283"/>
  <dbReference type="SwissPalm" id="Q13283"/>
  <dbReference type="BioMuta" id="G3BP1"/>
  <dbReference type="DMDM" id="14916572"/>
  <dbReference type="CPTAC" id="CPTAC-374"/>
  <dbReference type="jPOST" id="Q13283"/>
  <dbReference type="MassIVE" id="Q13283"/>
  <dbReference type="PaxDb" id="9606-ENSP00000377681"/>
  <dbReference type="PeptideAtlas" id="Q13283"/>
  <dbReference type="ProteomicsDB" id="59275">
    <molecule id="Q13283-1"/>
  </dbReference>
  <dbReference type="ProteomicsDB" id="62931"/>
  <dbReference type="Pumba" id="Q13283"/>
  <dbReference type="Antibodypedia" id="1315">
    <property type="antibodies" value="632 antibodies from 37 providers"/>
  </dbReference>
  <dbReference type="DNASU" id="10146"/>
  <dbReference type="Ensembl" id="ENST00000356245.8">
    <molecule id="Q13283-1"/>
    <property type="protein sequence ID" value="ENSP00000348578.3"/>
    <property type="gene ID" value="ENSG00000145907.16"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000394123.7">
    <molecule id="Q13283-1"/>
    <property type="protein sequence ID" value="ENSP00000377681.3"/>
    <property type="gene ID" value="ENSG00000145907.16"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000522367.6">
    <molecule id="Q13283-2"/>
    <property type="protein sequence ID" value="ENSP00000428926.1"/>
    <property type="gene ID" value="ENSG00000145907.16"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000522761.6">
    <molecule id="Q13283-1"/>
    <property type="protein sequence ID" value="ENSP00000430480.2"/>
    <property type="gene ID" value="ENSG00000145907.16"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000676827.1">
    <molecule id="Q13283-1"/>
    <property type="protein sequence ID" value="ENSP00000504627.1"/>
    <property type="gene ID" value="ENSG00000145907.16"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000676978.1">
    <molecule id="Q13283-1"/>
    <property type="protein sequence ID" value="ENSP00000503939.1"/>
    <property type="gene ID" value="ENSG00000145907.16"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000677323.1">
    <molecule id="Q13283-1"/>
    <property type="protein sequence ID" value="ENSP00000502880.1"/>
    <property type="gene ID" value="ENSG00000145907.16"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000677381.1">
    <molecule id="Q13283-2"/>
    <property type="protein sequence ID" value="ENSP00000504403.1"/>
    <property type="gene ID" value="ENSG00000145907.16"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000678070.1">
    <molecule id="Q13283-1"/>
    <property type="protein sequence ID" value="ENSP00000503039.1"/>
    <property type="gene ID" value="ENSG00000145907.16"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000678101.1">
    <molecule id="Q13283-1"/>
    <property type="protein sequence ID" value="ENSP00000504140.1"/>
    <property type="gene ID" value="ENSG00000145907.16"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000678925.1">
    <molecule id="Q13283-1"/>
    <property type="protein sequence ID" value="ENSP00000503699.1"/>
    <property type="gene ID" value="ENSG00000145907.16"/>
  </dbReference>
  <dbReference type="GeneID" id="10146"/>
  <dbReference type="KEGG" id="hsa:10146"/>
  <dbReference type="MANE-Select" id="ENST00000356245.8">
    <property type="protein sequence ID" value="ENSP00000348578.3"/>
    <property type="RefSeq nucleotide sequence ID" value="NM_005754.3"/>
    <property type="RefSeq protein sequence ID" value="NP_005745.1"/>
  </dbReference>
  <dbReference type="UCSC" id="uc063iwq.1">
    <molecule id="Q13283-1"/>
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="AGR" id="HGNC:30292"/>
  <dbReference type="CTD" id="10146"/>
  <dbReference type="DisGeNET" id="10146"/>
  <dbReference type="GeneCards" id="G3BP1"/>
  <dbReference type="HGNC" id="HGNC:30292">
    <property type="gene designation" value="G3BP1"/>
  </dbReference>
  <dbReference type="HPA" id="ENSG00000145907">
    <property type="expression patterns" value="Low tissue specificity"/>
  </dbReference>
  <dbReference type="MIM" id="608431">
    <property type="type" value="gene"/>
  </dbReference>
  <dbReference type="neXtProt" id="NX_Q13283"/>
  <dbReference type="OpenTargets" id="ENSG00000145907"/>
  <dbReference type="PharmGKB" id="PA162389105"/>
  <dbReference type="VEuPathDB" id="HostDB:ENSG00000145907"/>
  <dbReference type="eggNOG" id="KOG0116">
    <property type="taxonomic scope" value="Eukaryota"/>
  </dbReference>
  <dbReference type="GeneTree" id="ENSGT00390000011365"/>
  <dbReference type="HOGENOM" id="CLU_022209_0_2_1"/>
  <dbReference type="InParanoid" id="Q13283"/>
  <dbReference type="OMA" id="ISDRQCY"/>
  <dbReference type="OrthoDB" id="5491654at2759"/>
  <dbReference type="PhylomeDB" id="Q13283"/>
  <dbReference type="TreeFam" id="TF325464"/>
  <dbReference type="PathwayCommons" id="Q13283"/>
  <dbReference type="Reactome" id="R-HSA-9705671">
    <property type="pathway name" value="SARS-CoV-2 activates/modulates innate and adaptive immune responses"/>
  </dbReference>
  <dbReference type="SignaLink" id="Q13283"/>
  <dbReference type="SIGNOR" id="Q13283"/>
  <dbReference type="BioGRID-ORCS" id="10146">
    <property type="hits" value="45 hits in 1161 CRISPR screens"/>
  </dbReference>
  <dbReference type="ChiTaRS" id="G3BP1">
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="EvolutionaryTrace" id="Q13283"/>
  <dbReference type="GeneWiki" id="G3BP1"/>
  <dbReference type="GenomeRNAi" id="10146"/>
  <dbReference type="Pharos" id="Q13283">
    <property type="development level" value="Tbio"/>
  </dbReference>
  <dbReference type="PRO" id="PR:Q13283"/>
  <dbReference type="Proteomes" id="UP000005640">
    <property type="component" value="Chromosome 5"/>
  </dbReference>
  <dbReference type="RNAct" id="Q13283">
    <property type="molecule type" value="protein"/>
  </dbReference>
  <dbReference type="Bgee" id="ENSG00000145907">
    <property type="expression patterns" value="Expressed in ventricular zone and 209 other cell types or tissues"/>
  </dbReference>
  <dbReference type="ExpressionAtlas" id="Q13283">
    <property type="expression patterns" value="baseline and differential"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005737">
    <property type="term" value="C:cytoplasm"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0010494">
    <property type="term" value="C:cytoplasmic stress granule"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005829">
    <property type="term" value="C:cytosol"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HPA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005925">
    <property type="term" value="C:focal adhesion"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005634">
    <property type="term" value="C:nucleus"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="GO" id="GO:0043204">
    <property type="term" value="C:perikaryon"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-SubCell"/>
  </dbReference>
  <dbReference type="GO" id="GO:1990904">
    <property type="term" value="C:ribonucleoprotein complex"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005524">
    <property type="term" value="F:ATP binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016887">
    <property type="term" value="F:ATP hydrolysis activity"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="RHEA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003677">
    <property type="term" value="F:DNA binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003678">
    <property type="term" value="F:DNA helicase activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="FlyBase"/>
  </dbReference>
  <dbReference type="GO" id="GO:0033677">
    <property type="term" value="F:DNA/RNA helicase activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="FlyBase"/>
  </dbReference>
  <dbReference type="GO" id="GO:0004519">
    <property type="term" value="F:endonuclease activity"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0140693">
    <property type="term" value="F:molecular condensate scaffold activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003729">
    <property type="term" value="F:mRNA binding"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0043024">
    <property type="term" value="F:ribosomal small subunit binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003723">
    <property type="term" value="F:RNA binding"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003724">
    <property type="term" value="F:RNA helicase activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="FlyBase"/>
  </dbReference>
  <dbReference type="GO" id="GO:0051607">
    <property type="term" value="P:defense response to virus"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045087">
    <property type="term" value="P:innate immune response"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0090090">
    <property type="term" value="P:negative regulation of canonical Wnt signaling pathway"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0062029">
    <property type="term" value="P:positive regulation of stress granule assembly"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0032481">
    <property type="term" value="P:positive regulation of type I interferon production"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0007265">
    <property type="term" value="P:Ras protein signal transduction"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="GO" id="GO:0034063">
    <property type="term" value="P:stress granule assembly"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="CDD" id="cd00780">
    <property type="entry name" value="NTF2"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="CDD" id="cd12463">
    <property type="entry name" value="RRM_G3BP1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="3.10.450.50">
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="3.30.70.330">
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR034374">
    <property type="entry name" value="G3BP1_RRM"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR032710">
    <property type="entry name" value="NTF2-like_dom_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR002075">
    <property type="entry name" value="NTF2_dom"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR018222">
    <property type="entry name" value="Nuclear_transport_factor_2_euk"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR012677">
    <property type="entry name" value="Nucleotide-bd_a/b_plait_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR039539">
    <property type="entry name" value="Ras_GTPase_bind_prot"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR035979">
    <property type="entry name" value="RBD_domain_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR000504">
    <property type="entry name" value="RRM_dom"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR10693">
    <property type="entry name" value="RAS GTPASE-ACTIVATING PROTEIN-BINDING PROTEIN"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR10693:SF21">
    <property type="entry name" value="RAS GTPASE-ACTIVATING PROTEIN-BINDING PROTEIN 1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF02136">
    <property type="entry name" value="NTF2"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF00076">
    <property type="entry name" value="RRM_1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SMART" id="SM00360">
    <property type="entry name" value="RRM"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF54427">
    <property type="entry name" value="NTF2-like"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF54928">
    <property type="entry name" value="RNA-binding domain, RBD"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS50177">
    <property type="entry name" value="NTF2_DOMAIN"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS50102">
    <property type="entry name" value="RRM"/>
    <property type="match status" value="1"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0002">3D-structure</keyword>
  <keyword id="KW-0007">Acetylation</keyword>
  <keyword id="KW-0025">Alternative splicing</keyword>
  <keyword id="KW-0067">ATP-binding</keyword>
  <keyword id="KW-0963">Cytoplasm</keyword>
  <keyword id="KW-0903">Direct protein sequencing</keyword>
  <keyword id="KW-0238">DNA-binding</keyword>
  <keyword id="KW-0255">Endonuclease</keyword>
  <keyword id="KW-0347">Helicase</keyword>
  <keyword id="KW-0945">Host-virus interaction</keyword>
  <keyword id="KW-0378">Hydrolase</keyword>
  <keyword id="KW-0391">Immunity</keyword>
  <keyword id="KW-0399">Innate immunity</keyword>
  <keyword id="KW-1017">Isopeptide bond</keyword>
  <keyword id="KW-0488">Methylation</keyword>
  <keyword id="KW-0540">Nuclease</keyword>
  <keyword id="KW-0547">Nucleotide-binding</keyword>
  <keyword id="KW-0539">Nucleus</keyword>
  <keyword id="KW-0597">Phosphoprotein</keyword>
  <keyword id="KW-1267">Proteomics identification</keyword>
  <keyword id="KW-1185">Reference proteome</keyword>
  <keyword id="KW-0694">RNA-binding</keyword>
  <keyword id="KW-0813">Transport</keyword>
  <keyword id="KW-0832">Ubl conjugation</keyword>
  <feature type="initiator methionine" description="Removed" evidence="40">
    <location>
      <position position="1"/>
    </location>
  </feature>
  <feature type="chain" id="PRO_0000194798" description="Ras GTPase-activating protein-binding protein 1">
    <location>
      <begin position="2"/>
      <end position="466"/>
    </location>
  </feature>
  <feature type="domain" description="NTF2" evidence="2">
    <location>
      <begin position="11"/>
      <end position="133"/>
    </location>
  </feature>
  <feature type="domain" description="RRM" evidence="3">
    <location>
      <begin position="340"/>
      <end position="415"/>
    </location>
  </feature>
  <feature type="region of interest" description="Acidic disordered region" evidence="28 30">
    <location>
      <begin position="142"/>
      <end position="225"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="28 29 30">
    <location>
      <begin position="144"/>
      <end position="172"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="28 29 30">
    <location>
      <begin position="184"/>
      <end position="243"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="4">
    <location>
      <begin position="255"/>
      <end position="329"/>
    </location>
  </feature>
  <feature type="region of interest" description="RG-rich region" evidence="28 30">
    <location>
      <begin position="410"/>
      <end position="466"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="4">
    <location>
      <begin position="413"/>
      <end position="466"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Acidic residues" evidence="4">
    <location>
      <begin position="188"/>
      <end position="206"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Basic and acidic residues" evidence="4">
    <location>
      <begin position="207"/>
      <end position="223"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Polar residues" evidence="4">
    <location>
      <begin position="225"/>
      <end position="243"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Basic and acidic residues" evidence="4">
    <location>
      <begin position="413"/>
      <end position="430"/>
    </location>
  </feature>
  <feature type="site" description="Cleavage; by human enterovirus 71 protease 3C" evidence="23">
    <location>
      <begin position="325"/>
      <end position="326"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphothreonine" evidence="51">
    <location>
      <position position="143"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="6 29 30 47 48 49 50 51 52 55 56 57 59">
    <location>
      <position position="149"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="40">
    <location>
      <position position="231"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="6 30 40 51 54 55 56 59">
    <location>
      <position position="232"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="57">
    <location>
      <position position="250"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="57">
    <location>
      <position position="253"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="51 55">
    <location>
      <position position="373"/>
    </location>
  </feature>
  <feature type="modified residue" description="N6-acetyllysine; alternate" evidence="53">
    <location>
      <position position="376"/>
    </location>
  </feature>
  <feature type="modified residue" description="Asymmetric dimethylarginine" evidence="58">
    <location>
      <position position="429"/>
    </location>
  </feature>
  <feature type="modified residue" description="Asymmetric dimethylarginine; alternate" evidence="58">
    <location>
      <position position="435"/>
    </location>
  </feature>
  <feature type="modified residue" description="Dimethylated arginine; alternate" evidence="40">
    <location>
      <position position="435"/>
    </location>
  </feature>
  <feature type="modified residue" description="Omega-N-methylarginine; alternate" evidence="40 58">
    <location>
      <position position="435"/>
    </location>
  </feature>
  <feature type="modified residue" description="Omega-N-methylarginine" evidence="58">
    <location>
      <position position="447"/>
    </location>
  </feature>
  <feature type="modified residue" description="Dimethylated arginine; alternate" evidence="40">
    <location>
      <position position="460"/>
    </location>
  </feature>
  <feature type="modified residue" description="Omega-N-methylarginine; alternate" evidence="40 58">
    <location>
      <position position="460"/>
    </location>
  </feature>
  <feature type="modified residue" description="Omega-N-methylarginine" evidence="58">
    <location>
      <position position="465"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="31">
    <location>
      <position position="36"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="31">
    <location>
      <position position="50"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="31">
    <location>
      <position position="59"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="31">
    <location>
      <position position="64"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="44">
    <location>
      <position position="76"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="44">
    <location>
      <position position="123"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="44">
    <location>
      <position position="353"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="44">
    <location>
      <position position="357"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="60">
    <location>
      <position position="376"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="44">
    <location>
      <position position="376"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate" evidence="44">
    <location>
      <position position="393"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_056280" description="In isoform 2." evidence="41 42">
    <original>GSVAN</original>
    <variation>SLKKK</variation>
    <location>
      <begin position="118"/>
      <end position="122"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_056281" description="In isoform 2." evidence="41 42">
    <location>
      <begin position="123"/>
      <end position="466"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_088949" description="Found in a patient with a neurodevelopmental disorder; uncertain significance; decreased function in stress granule formation shown by rescue assays in transfected G3BP1-deficient cells." evidence="33">
    <original>R</original>
    <variation>C</variation>
    <location>
      <position position="78"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_088950" description="Found in a patient with a neurodevelopmental disorder; uncertain significance; decreased function in stress granule formation shown by rescue assays in transfected G3BP1-deficient cells." evidence="33">
    <original>R</original>
    <variation>I</variation>
    <location>
      <position position="132"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_088951" description="Found in a patient with a neurodevelopmental disorder; uncertain significance; decreased function in stress granule formation shown by rescue assays in transfected G3BP1-deficient cells." evidence="33">
    <original>S</original>
    <variation>C</variation>
    <location>
      <position position="208"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_088952" description="Found in a patient with a neurodevelopmental disorder; uncertain significance; decreased function in stress granule formation shown by rescue assays in transfected G3BP1-deficient cells." evidence="33">
    <original>R</original>
    <variation>C</variation>
    <location>
      <position position="320"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_088953" description="Found in a patient with a neurodevelopmental disorder; uncertain significance; no effect on function in stress granule formation shown by rescue assays in transfected G3BP1-deficient cells." evidence="33">
    <original>V</original>
    <variation>M</variation>
    <location>
      <position position="366"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decreased interaction with USP10." evidence="34">
    <original>F</original>
    <variation>W</variation>
    <location>
      <position position="15"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished interaction with CAPRIN1 and ability to undergo liquid-liquid phase separation. Abolished interaction with USP10." evidence="19 29 35">
    <original>F</original>
    <variation>W</variation>
    <location>
      <position position="33"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="In 10KR; abolished ubiquitination in response to heat shock, leading to decreased stress granule disassembly when associated with R-50, R-59, R-64, R-76, R-123, R-353, R-357, R-376 and R-393. In 6KR; strongly decreased ubiquitination in response to heat shock, leading to decreased stress granule disassembly; when associated with R-50, R-59, R-64, R-76 and R-123. In 4KR; decreased ubiquitination in response to heat shock, leading to slightly decreased stress granule disassembly; when associated with R-50, R-59 and R-64." evidence="31">
    <original>K</original>
    <variation>R</variation>
    <location>
      <position position="36"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="In 10KR; abolished ubiquitination in response to heat shock, leading to decreased stress granule disassembly when associated with R-36, R-59, R-64, R-76, R-123, R-353, R-357, R-376 and R-393. In 6KR; strongly decreased ubiquitination in response to heat shock, leading to decreased stress granule disassembly; when associated with R-36, R-59, R-64, R-76 and R-123. In 4KR; decreased ubiquitination in response to heat shock, leading to slightly decreased stress granule disassembly; when associated with R-36, R-59 and R-64." evidence="31">
    <original>K</original>
    <variation>R</variation>
    <location>
      <position position="50"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="In 10KR; abolished ubiquitination in response to heat shock, leading to decreased stress granule disassembly when associated with R-36, R-50, R-64, R-76, R-123, R-353, R-357, R-376 and R-393. In 6KR; strongly decreased ubiquitination in response to heat shock, leading to decreased stress granule disassembly; when associated with R-36, R-50, R-64, R-76 and R-123. In 4KR; decreased ubiquitination in response to heat shock, leading to slightly decreased stress granule disassembly; when associated with R-36, R-50 and R-64." evidence="31">
    <original>K</original>
    <variation>R</variation>
    <location>
      <position position="59"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="In 10KR; abolished ubiquitination in response to heat shock, leading to decreased stress granule disassembly when associated with R-36, R-50, R-59, R-76, R-123, R-353, R-357, R-376 and R-393. In 6KR; strongly decreased ubiquitination in response to heat shock, leading to decreased stress granule disassembly; when associated with R-36, R-50, R-59, R-76 and R-123. In 4KR; decreased ubiquitination in response to heat shock, leading to slightly decreased stress granule disassembly; when associated with R-36, R-50 and R-59." evidence="31">
    <original>K</original>
    <variation>R</variation>
    <location>
      <position position="64"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="In 10KR; abolished ubiquitination in response to heat shock, leading to decreased stress granule disassembly when associated with R-36, R-50, R-59, R-64, R-123, R-353, R-357, R-376 and R-393. In 6KR; strongly decreased ubiquitination in response to heat shock, leading to decreased stress granule disassembly; when associated with R-36, R-50, R-59, R-64 and R-123." evidence="31">
    <original>K</original>
    <variation>R</variation>
    <location>
      <position position="76"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="In 10KR; abolished ubiquitination in response to heat shock, leading to decreased stress granule disassembly when associated with R-36, R-50, R-59, R-64, R-76, R-353, R-357, R-376 and R-393. In 6KR; strongly decreased ubiquitination in response to heat shock, leading to decreased stress granule disassembly; when associated with R-36, R-50, R-59, R-64 and R-76." evidence="31">
    <original>K</original>
    <variation>R</variation>
    <location>
      <position position="123"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect interaction with USP10." evidence="34">
    <original>F</original>
    <variation>W</variation>
    <location>
      <position position="124"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Slightly increased ability to undergo liquid-liquid phase separation. Increased ability to undergo liquid-liquid phase separation; when associated with A-232. Cytoplasmic." evidence="6 7 29 30">
    <original>S</original>
    <variation>A</variation>
    <location>
      <position position="149"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Mimics phosphorylation; decreased ability to undergo liquid-liquid phase separation. Cytoplasmic and nuclear; no assembly of stress granules; no homo-oligomerization." evidence="6 7 29">
    <original>S</original>
    <variation>E</variation>
    <location>
      <position position="149"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Slightly increased ability to undergo liquid-liquid phase separation; when associated with A-149. Cytoplasmic. Partially nuclear; when associated with E-149." evidence="6 30">
    <original>S</original>
    <variation>A</variation>
    <location>
      <position position="232"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Cytoplasmic. Partially nuclear; when associated with E-149." evidence="6">
    <original>S</original>
    <variation>E</variation>
    <location>
      <position position="232"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of cleavage by human enterovirus 71 protease 3C." evidence="23">
    <original>Q</original>
    <variation>G</variation>
    <location>
      <position position="325"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="In 10KR; abolished ubiquitination in response to heat shock, leading to decreased stress granule disassembly when associated with R-36, R-50, R-59, R-64, R-76, R-123,R-357, R-376 and R-393." evidence="31">
    <original>K</original>
    <variation>R</variation>
    <location>
      <position position="353"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="In 10KR; abolished ubiquitination in response to heat shock, leading to decreased stress granule disassembly when associated with R-36, R-50, R-59, R-64, R-76, R-123, R-353, R-376 and R-393." evidence="31">
    <original>K</original>
    <variation>R</variation>
    <location>
      <position position="357"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="In 10KR; abolished ubiquitination in response to heat shock, leading to decreased stress granule disassembly when associated with R-36, R-50, R-59, R-64, R-76, R-123, R-353, R-357 and R-393." evidence="31">
    <original>K</original>
    <variation>R</variation>
    <location>
      <position position="376"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished mRNA-binding and ability to undergo liquid-liquid phase separation." evidence="29">
    <original>FGF</original>
    <variation>GDG</variation>
    <location>
      <begin position="380"/>
      <end position="382"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="In 10KR; abolished ubiquitination in response to heat shock, leading to decreased stress granule disassembly when associated with R-36, R-50, R-59, R-64, R-76, R-123, R-353, R-357 and R-376." evidence="31">
    <original>K</original>
    <variation>R</variation>
    <location>
      <position position="393"/>
    </location>
  </feature>
  <feature type="helix" evidence="61">
    <location>
      <begin position="8"/>
      <end position="25"/>
    </location>
  </feature>
  <feature type="helix" evidence="61">
    <location>
      <begin position="27"/>
      <end position="33"/>
    </location>
  </feature>
  <feature type="strand" evidence="61">
    <location>
      <begin position="34"/>
      <end position="41"/>
    </location>
  </feature>
  <feature type="strand" evidence="63">
    <location>
      <begin position="49"/>
      <end position="51"/>
    </location>
  </feature>
  <feature type="helix" evidence="61">
    <location>
      <begin position="57"/>
      <end position="67"/>
    </location>
  </feature>
  <feature type="strand" evidence="61">
    <location>
      <begin position="74"/>
      <end position="84"/>
    </location>
  </feature>
  <feature type="helix" evidence="61">
    <location>
      <begin position="86"/>
      <end position="88"/>
    </location>
  </feature>
  <feature type="strand" evidence="61">
    <location>
      <begin position="90"/>
      <end position="99"/>
    </location>
  </feature>
  <feature type="helix" evidence="62">
    <location>
      <begin position="100"/>
      <end position="102"/>
    </location>
  </feature>
  <feature type="strand" evidence="61">
    <location>
      <begin position="106"/>
      <end position="116"/>
    </location>
  </feature>
  <feature type="strand" evidence="61">
    <location>
      <begin position="118"/>
      <end position="120"/>
    </location>
  </feature>
  <feature type="strand" evidence="61">
    <location>
      <begin position="124"/>
      <end position="134"/>
    </location>
  </feature>
  <feature type="helix" evidence="63">
    <location>
      <begin position="135"/>
      <end position="138"/>
    </location>
  </feature>
  <evidence type="ECO:0000250" key="1">
    <source>
      <dbReference type="UniProtKB" id="P97855"/>
    </source>
  </evidence>
  <evidence type="ECO:0000255" key="2">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU00137"/>
    </source>
  </evidence>
  <evidence type="ECO:0000255" key="3">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU00176"/>
    </source>
  </evidence>
  <evidence type="ECO:0000256" key="4">
    <source>
      <dbReference type="SAM" id="MobiDB-lite"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="5">
    <source>
      <dbReference type="PubMed" id="11439350"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="6">
    <source>
      <dbReference type="PubMed" id="11604510"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="7">
    <source>
      <dbReference type="PubMed" id="12642610"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="8">
    <source>
      <dbReference type="PubMed" id="17210633"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="9">
    <source>
      <dbReference type="PubMed" id="18684830"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="10">
    <source>
      <dbReference type="PubMed" id="20180778"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="11">
    <source>
      <dbReference type="PubMed" id="23087212"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="12">
    <source>
      <dbReference type="PubMed" id="23209657"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="13">
    <source>
      <dbReference type="PubMed" id="23279204"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="14">
    <source>
      <dbReference type="PubMed" id="23785203"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="15">
    <source>
      <dbReference type="PubMed" id="23953116"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="16">
    <source>
      <dbReference type="PubMed" id="24324649"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="17">
    <source>
      <dbReference type="PubMed" id="24623412"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="18">
    <source>
      <dbReference type="PubMed" id="25658430"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="19">
    <source>
      <dbReference type="PubMed" id="27022092"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="20">
    <source>
      <dbReference type="PubMed" id="27383630"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="21">
    <source>
      <dbReference type="PubMed" id="28592527"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="22">
    <source>
      <dbReference type="PubMed" id="28794026"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="23">
    <source>
      <dbReference type="PubMed" id="30006004"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="24">
    <source>
      <dbReference type="PubMed" id="30404792"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="25">
    <source>
      <dbReference type="PubMed" id="30510222"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="26">
    <source>
      <dbReference type="PubMed" id="30804210"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="27">
    <source>
      <dbReference type="PubMed" id="31981475"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="28">
    <source>
      <dbReference type="PubMed" id="32302570"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="29">
    <source>
      <dbReference type="PubMed" id="32302571"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="30">
    <source>
      <dbReference type="PubMed" id="32302572"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="31">
    <source>
      <dbReference type="PubMed" id="34739333"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="32">
    <source>
      <dbReference type="PubMed" id="34779554"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="33">
    <source>
      <dbReference type="PubMed" id="35977029"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="34">
    <source>
      <dbReference type="PubMed" id="36183834"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="35">
    <source>
      <dbReference type="PubMed" id="36279435"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="36">
    <source>
      <dbReference type="PubMed" id="36692217"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="37">
    <source>
      <dbReference type="PubMed" id="37379838"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="38">
    <source>
      <dbReference type="PubMed" id="8649363"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="39">
    <source>
      <dbReference type="PubMed" id="9889278"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="40">
    <source ref="6"/>
  </evidence>
  <evidence type="ECO:0000303" key="41">
    <source>
      <dbReference type="PubMed" id="14702039"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="42">
    <source>
      <dbReference type="PubMed" id="17974005"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="43">
    <source>
      <dbReference type="PubMed" id="23279204"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="44">
    <source>
      <dbReference type="PubMed" id="34739333"/>
    </source>
  </evidence>
  <evidence type="ECO:0000312" key="45">
    <source>
      <dbReference type="HGNC" id="HGNC:30292"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="46">
    <source>
      <dbReference type="PDB" id="7S17"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="47">
    <source>
      <dbReference type="PubMed" id="17081983"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="48">
    <source>
      <dbReference type="PubMed" id="17693683"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="49">
    <source>
      <dbReference type="PubMed" id="18220336"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="50">
    <source>
      <dbReference type="PubMed" id="18318008"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="51">
    <source>
      <dbReference type="PubMed" id="18669648"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="52">
    <source>
      <dbReference type="PubMed" id="18691976"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="53">
    <source>
      <dbReference type="PubMed" id="19608861"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="54">
    <source>
      <dbReference type="PubMed" id="19690332"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="55">
    <source>
      <dbReference type="PubMed" id="20068231"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="56">
    <source>
      <dbReference type="PubMed" id="21406692"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="57">
    <source>
      <dbReference type="PubMed" id="23186163"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="58">
    <source>
      <dbReference type="PubMed" id="24129315"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="59">
    <source>
      <dbReference type="PubMed" id="24275569"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="60">
    <source>
      <dbReference type="PubMed" id="28112733"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="61">
    <source>
      <dbReference type="PDB" id="4FCJ"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="62">
    <source>
      <dbReference type="PDB" id="4IIA"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="63">
    <source>
      <dbReference type="PDB" id="8TH1"/>
    </source>
  </evidence>
  <sequence length="466" mass="52164" checksum="0F9429D78E0C7F59" modified="1996-11-01" version="1">MVMEKPSPLLVGREFVRQYYTLLNQAPDMLHRFYGKNSSYVHGGLDSNGKPADAVYGQKEIHRKVMSQNFTNCHTKIRHVDAHATLNDGVVVQVMGLLSNNNQALRRFMQTFVLAPEGSVANKFYVHNDIFRYQDEVFGGFVTEPQEESEEEVEEPEERQQTPEVVPDDSGTFYDQAVVSNDMEEHLEEPVAEPEPDPEPEPEQEPVSEIQEEKPEPVLEETAPEDAQKSSSPAPADIAQTVQEDLRTFSWASVTSKNLPPSGAVPVTGIPPHVVKVPASQPRPESKPESQIPPQRPQRDQRVREQRINIPPQRGPRPIREAGEQGDIEPRRMVRHPDSHQLFIGNLPHEVDKSELKDFFQSYGNVVELRINSGGKLPNFGFVVFDDSEPVQKVLSNRPIMFRGEVRLNVEEKKTRAAREGDRRDNRLRGPGGPRGGLGGGMRGPPRGGMVQKPGFGVGRGLAPRQ</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>